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INTRODUCTION 
 
Siddha system is well founded on the basic principles of nature and its elements, and it 
offers a careful and through study of the human and animal systems. Siddha science considers 
nature and human as essentially one. One who knows the secrecy of nature and its five elements 
know well the secerecy of human. 
 
According to siddha medical science the universe consists of five elements (Pancha 
boothas) namely earth, water, fire, air and ether (Aakayam) which corresponded to the five 
senses of the human body. 
 
The three vital forces namely vali(vatham) Azhal (pitham), Ayyam(Kabam) called as uyir 
thathukkal are activated by the functions of pancha boothas. According to the pancha bootha 
theory all the substances in the universe are created by the actions (or) reactions of the pancha 
bootha only. 
 
“ capHf;fhjhuk; capHjhnjdTk; 
Kg;gphpthfp Kf;Fz kZfp 
cliyAk; capiuAk; Nkhk; gpf;fhj;J 
tUnkd; KJkiw tFf;Fe; JzpNa". 
 
In heavily persons the tridoshas maintain proper functioning of all the organs and tissues 
depending upon individual needs. 
            Siddha system of medicine is also known for its simple principle. 
 
"czNt kUe;J kUe;Nj czT" 
 
Which is also said by Hippocrates as 
 
“Let thy food be medicine.  
And the medicine be thy food”. 
  
 
 
The two words food & medicine denote the same meaning  In health it is taken as food and taken 
as medicine in ill-health where its dosage only differs. 
 
The formulations of six tastes  from five elements (Pancha boothas) their role in siddha medical 
formulations Principles are well known. 
 
It is of paramount importance to acquire international acceptance of our own siddha system of 
medicine is of almost importance and demanding in this current situation.   This brings the need 
for scientific investigation  of herbs used in siddha system using the modern parameters & 
methods of study like phytochemistry. Biochemical analysis, Pharmacological study clinical 
trial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
AIM AND OBJECTIVE 
AIM: 
 
To evaluate the anti histaminic and anti-inflammatory action and efficacy of kudasapalai 
pattai chooranam for the treatment of karappan. 
 
OBJECTIVE: 
 
To main objective of the present study is to highlight the efficacy of the drug  through 
 
1. collection of various literature. 
2. bio-chemical analysis 
3. physical properties 
4. acute toxicity 
5. pharmacological  study 
6. clinical study 
 
 
 
 
 
 
 
  
 
Flrg;ghiy10 
 
Botanical Name   : Holarrhena Pubescens (or) 
                                                                 Holarrhena antidysentrica 
 
NtWngaHfs;    : frg;G> ntl;ghiy> Fsg;ghiy> 
         Fsg;ghis. 
Note 
There are two kinds of  vetptalai in the bazaar, seet and bitter according to some native works 
and many native practitioners and druggists.  They are the produce of one and same plant viz 
wrightia Tinctoria (ntl;ghiy) but this is the contrary to the fact tinctoria is found in several 
gardens of Chennai and else where and always produces only one kind of seeds which are sweet  
(ntl;ghiy) 
,J fhLfspy; tsUk; kuk; fWg;G> nts;is vd ,U tif cz;L. 
 
gad;gLk; cWg;Gfs;  - gl;il> tpij 
 
Rit    - JtHg;G> rpWifg;G 
jd;ik   - ntg;gk; 
gphpT    - ,dpg;G 
 
nra;if   - gl;il 
grpj;jPj;J}z;b 
ntg;gfw;wp 
GOf;nfhy;yp 
Fzk;: 
“thjkWk; Ngjpfl;L khwhj ePhpopTq; 
   fhjk;Ngh Nkfq; flf;Fq; fhz; - jPjlug; 
 nghq;F fug;ghDk; Nghfh tpuzKk; Nghk; 
 ,q;F Fl rg;ghiyf; Nf” 
 
nghUs;: 
 
  
,jdhy; tsp Neha;> fopr;ry;> ePhpopT> nts;is> fug;ghd;> rpuq;F Nghk;.  md;wpAk; 
Ruk; ePq;Fk;. 
 
“Rthrfh rk;gf;fr; R+iyajp rhuk; 
 Mthr tpaHg;Ngh ldye; - jthj 
 fug;gh dpit tpyFq; fhhpifNa! ehSk; 
 cug;ghq; Fsg;ghiy Az;” 
 
Rthrfhrk;> gf;f R+iy> mjprhuk;> Ruk;> fug;ghd; Nghd;wit jPUk;. 
 
 
gad;fs;:24 
D gl;ilia Kiwg;gb FbePhpl;L 15kpyp – 30kpyp  -  tiu jpdKk; %d;W Ntis 
nfhLj;J tu fopr;ry; tifahTk; Nghk;. 
D gl;ilia gpope;J rhnwLj;J ,Q;rpr;rhW xU epiw NrHj;J mj;Jld; rpwpJ 
rHf;fiu NrHj;J rhg;gpl;L tu tapw;W Neha;> Nkf Neha; Nghd;witfisf; 
fz;bf;Fk;. 
D gl;ilia FbePhpl;L tha; nfhg;Gspf;f gy;typ jPUk;. 
D gl;il rhw;iw vz;nzapypl;L fha;r;rp fug;ghd;> nrhwp> rpuq;F Kjypa 
Neha;fSf;F jlt ed;ik jUk;. 
D gl;iliar; rpijj;J typAs;s ,lq;fspy; itj;J fl;l ed;ik gaf;Fk;. 
D gl;il 8 fpuhk; tpy;t gor;rij 8fp khJsk; gl;il 4 fpuhk; ,k;%d;iwAk; 
cyHj;jp nghb nra;J 1 fp – 2 fp vil tpfpjk; Njdpy; (m) rHf;fiuapy; fye;J 
nfhLf;f fopr;ry;fs; Nghk;. 
 
 
 
 
 
 
  
BOTANICAL ASPECT 17 
 
The drug kudasapalai pattai indicated for karappan in siddha literatures. In this 
dissertation the author has to evaluate the Anti-histaminic and Anti-Inflammatory activity of 
kudasapalai pattai chooranam. 
 
According to Benthem Hooker classification13 
Holarrhena antidysenterica. 
 
Kingdom  : Plant kingdom 
Division   : Phanerograms 
Sub division   :  Angios perms 
Class                          :            Dicotyledons 
Subclass  : Gamo petalae 
Series   : Bicarpellatae. 
Order   : Gentianales 
Family   : Apocynaceae 
Genius   : Holarrhena 
Species  : Pubescans/ antidysentrica. 
 
BOTANICAL ASPECT 17 
 
Botanical Name : Holarrhena antidysentrica 
Common Name :  Bitter oleander, connessi bark, kurchi bark, 
                                                Dysentry Rose Bay. 
Ayurvedic Name :  Kutaja, Girimallikaa, Kaalinga, Indra Vrksha ,Vatsaka. 
Unani   : Teewaaj, kurchi (bark ), Inderjao talkh, (seeds) 
Siddha   : Kudasapalai pattai. 
English  : Easter tree, Tellicherry bark. 
Tel    : Chedu-Kodisha 
Kan                             :            Korasigina-gida 
  
Mal   : Kaipa-kotakap-pala. 
Hind   : Karva-indarjow 
Sans   : Kutaja 
Arab   : Lasanul –aasafir. 
 
Family                        :           Apocynaceae 
 
Habitat: 
A native of the tropical Himalayas, going up to an altitude of 1100m.. Also found through 
out many forests of India in travan core, Assam and uttarpradesh. 
 
Part used                   :             Bark, seeds 
 
Collection: 
The maximum alkaloid content has been reported from bark collected soon after  
the rains (July-September) 
Average total alkaloid content in the plant stem-0.52% 
In addition to the alkaloids kurchi contains: 
Gam –9.50, resin-0.2; Tannin-1.14% 
Atri terpene, alcohol, lupeolhave been isolated from the unsaponifiable matter of the bark. 
 
Alkaloids:25 
The bark contains about 30 alkaloids concessive Nor-Conessine, Conessimine, Kurchine , Conimine, Conamaine, Conarrhimine, 
Holarrhire, Holarhessimine, Lettocine kurchicine. 
 
Constituents:25 
Barks and seeds contain Non-oxygenated alkaloid-Wrightine (or) conessine (or) 
kurchisine and Holarrhine wrightine (or)  conessine is an camorphous powder soluble in water 
and alcohol and in dilute acids. 
 
 
 
  
Action: 
Bark is bitter, stomachic, astringent, powerful antidysenteric, febrifuge and anthelmintic. 
The total alkaloids from the bark can be given in large doses and with out producing  depressant , 
emetic, irritative, effects. 
 
They are much less tonic than emetine. They produce a certain amount of local reaction. 
Pain and swelling which pass off in 24 hrs-48hrs. 
 
Classical use: 
 
Decoction of kutaja bark with shunti (Zingiber officinale) in diarrhoea with mucus and 
blood. Bark and seeds in prescriptions for fever and haemorrhage. 
Sushruka prescribed  seeds internally in amoebic dysentery externally. For malignant skin 
diseases. 
 
Kutaja seeds and bark were used in many single (or) compound ayruvedic formulations. 
-     a decoction of seeds (40gm) 
- seeds with barley –scum; 
- linctus of kutaja bark 
- a decoction of kutaja bark 
- seeds and musta(cyperus rotundus) 
- kutaja was considered the best single, Drug dirrhoea and dysentry. 
 
According to charaka samhita, kutaja is of 2 varieties male and female 
. 
Male variety: It has bigger fruits, white flowers, long leaves. 
Its bark is extremely red and thick. 
 
Female variety : Small fruits, flowers are round in shape and grayish red in colour. 
Bark in white colour. 
      Female variety considered inferior in quality a few scholars equate the male variety with 
Holarrhena and the female variety with wrightia.The male variety according to the 16th century. 
  
 
    Texts is astringent, constipative , cures haemorrhages, diarrhoea, menorrhagia and allied 
gynaecological disorders 
. 
     In unai medicine , Mostly female (or) white variety is used. Jawarish teewaj, Habb-e-teewaj 
are prescribed in diarrhoea , dysentery, haemorrhages and haemorrhoids. 
The bark powder mixed with curd is also prescribes. 
 
Active principles and pharmacology.14 
 
The bark contains about 30 alkolids, out of which conessine, kurchine, kurchicine, holarrrhimine, 
conarrhimine, conanine, conessimine, iso-concessimine conimine, holacetine and conkurchine. 
Amino glycosteroids are important the bark also have non alkaloids. 
 
The seeds have amino acids in free state as paretic and  arginine being the major ones. 
Conessine form the bark kills free living amoebae. It also kills Entamoeba histolytica in 
dysentric stools of experimentally infected kittens. 
Conessine produces little effect on trichomonas hominis but is lethal  to the flagellate protozon. 
 
In a clinical study on 40 cases of amoebiasis and giardiasis, the efficacy of kutaja in intestinal 
amoebiasis was 70% Good response was also observed in Entamoeba histolytica cyst- passers 
when treated with kutaja bark. 
 
The seeds were found cooling, appetising and  astringent to the bowels. Flowers  improved 
appetite. The seed oil showed an inhibitory effect against pathogenic keratinophillic fungi, 
maximum inhibition was noted against k.ajelloi and m. gypseum. 
 
 
 
 
 
  
Various active principles of the plant exhibited following properties: 
 
Conessine: amoebicidal 
Conkurchine hydro chloride: Hypotensive, vasodilator. 
Fruits: anti protozoal, anti cancer, hypoglycemic 
Fruits and stem bark: spasmolytic 
Stem bark :  cvs –active 
Seed oil: Anti-fungal 
 
The mother tincture prepared form the bark with 70% alcohol exerted maximum anti spasmodic 
activity as compared to other tinctures prepared with varying percentage of alcohol. 
 
Wrightia tinctoria is the sweet variety of kutaja 
. 
         Wrightia tinctoria food contain alpha-amyrin. Beta –sitosterol, urxolic and oleanolic acids. 
Stem bark:  Beta-amyrin; beta-sito sterol and lupeol 
Leaves:       Beta- amyrin properties ate the sama as those of Holarrhera anti dysenterica. 
 
THERAPEUTIC USES: 
The bark is used  as an astringent, anthelmintic, stomachic, febrifuge, anti 
dropsical,diuretic. 
 
In piles, colic, dyspepsia chest affections and as a remedy in disease of skin and spleen. 
 
It is a wEll known drug for amoebic dysentry, and other gastric disorders. 
 
It is also indicated for diarrhoea, indigestion flatulence and colic. 
 
The liquid Extract of bark is using for dysentery. Acute and chronic of both children and adults 
and also to its anti pyretic effect. 
 
  
An infusion of the root bark which is very bitter and most un palatable- amoebic dysentery. 
 
Tablets from the bark can be easily taken and when combined with emetine treatment are 
beneficial.Bark is uses also as lep (or) plaster applied in Rheumatism, and over the part of the 
abdomen which is most painful. 
 
They are also useful applications in pruritus, bad ulcers etc. 
 
The bark have a most remarkable action against acute and chronic forms of amoebic infection of 
the gut. 
 
Acute amoebic dysentry –Intra muscular injection of 1 grain(65mg)  of total alkaloids. Produce a 
cure at least as quickly as emetinine. 
 
Chronic- 10 grains (650 mg)  of the alkaloids BD for 10 days the injection in a large number of 
case. 
In very persistent cases a course 15 to 20 days is given according to the severity of the case. 
 
PREPARATIONS:15 
 
Decoction and  infusion (1 in 10) 
Dose: 30 ml- 90ml 
Tincture (1in 8) dose ½ -2 drachne. . 
Powder dose: ½ -1 mg 
Kurchine: dose: 130-325mg . 
Liquid extract  dose: 10 drachne/day. 
Can be given for 10 days with out the patients complaining of  an   
unwanted symptoms. 
Kurchine: use best given in  powder. 
 
  
Take bark 8 gms, Bael fruit 8 gms,  pomegranate bark (dried) 4 gms, Rub them together into a 
fine powder dose-(1-2 gms). 
 
Vehicle: honey (or) syrub used in diarrhoea and advanced stages of dysentery. 
 
Take of the bark of Holarrhena antidysentrica 5 and Sugar 5 parts. Mix and boil with water till 
reduced to a syrupy consistence; then add Carbonate of potash 2, Pencha lavana (Rock salt, 
Common salt, Goda Lavana i.e. sweet chloride of sodium, Sanchal salt & Bidda Lavana or vit 
Salt) 2, Drided slices of the root  of long pepper 3, flowers of Grislea tomentosa 4, seeds of 
Holarrhena antidysentrica 4, and Cumin seeds 4 Parts, and make a fine powder. Dose – 1 Gram. 
Vehicle. – Syrup. Used in acute and chronic dysentery. 
 
Take of the bark of Holarrhena antidysenterica 5, Bombax malabaricum 3, Rubia cordifolia 2, 
Cissampelos pareira 3, Bael fruit 5, Cyperus rotundus 6, flowers of Grislea tomentosa 6, Mica 2, 
and Lahuna sara 4 parts. Mix and make a powder. Dose – 10 to 15 grains. Used in menorrhagia 
and other uterine discharges. 
 
Take of Holarrhena antidysenterica seeds 5, long pepper 4, dried slices of the root or long pepper 
4, Solanum jaoquini 3 and Apium Graveolens 4 parts. Mix and make a powder. 
 Dose is (650-975 mg). Used to check vomiting, and in dyspepsia – (Khory). 
 
“The seeds of Holarrhaena antidysenterica are a never failing specific for dysentery and 
hemorrhoidal flux. Take of the powdered seeds ½part,  sugarcandy 4 parts. cold water 30 ml; to 
be kept for a few hours and then strained with a thin muslin cloth: the result is a white 
mucilaginous bitter infusion, which is to be given twice or thrice a day to an adult; for children 
the dose is proportionate to their age. If the infusion be prepared in large quantity, in the 
proporations mentioned. It will keep fresh for many days”-(Tukina.) 
 
 
 
 
  
 
MATERIALS AND METHODS 
 
 
COLLECTION OF THE DRUG: 
 
The dried stem barks of Kudasapalai Pattai (Holarrhena antidyrentirca) were 
obtainined from the drug market of Chennai and was identified by a botanist  of National 
Institution of siddha, Chennai-47. 
 
PRESERVATION AND STORAGE: 
Stem barks were dried in shade and made into fine powder and stored in air tight container. 
 
PURIFICATION OF CHOORNAM: 
 
Gmsh<hijz!hm<jm!S,v{l<!Sk<kq;!
u <^kqvgibl<! osb<K! wMk<k! Gmsh<hijz! hm<jm! S,v{k<kqx<G! sqxqK! hSuqe<! hiz<! uqm<M!
hqjsf<K! Gjmuie! yV! l{<! sm<cbqz<! hiZl<! fz<z! k{<{QVl<! sl! ntuig! gzf<K!
Dx<xq?! ns<sm<cbqe<! uibqz<! K~b<jlbie! K{qjbg<! ogiR<sl<! ht<tl<! uqPl<hc! gm<c!
nkqz<! Olx<hc! S,v{k<jkh<! hqm<M! li! juh<hK! Ohiz! juk<K! OlOz! sm<cjb! &c!
sf<Kuib<! upq!Nuq! Ohigikhc! K{q! Sx<xq! nMh<hqe<! Olz<! juk<K! hiz<! S{<m! wiqk<K!
wMk<K! nkje! oub<bqzqz<! dzIk<kq! lXhcBl<! ohick<K! K{qbqz<! ucgm<c! wMk<Kg<!
ogit<th<hm<mK/!
 
 
 
  
BIO-CHEMICAL ANALYSIS 
 
 
PHYSICAL PROPERTIES 
 
The standardization parameters of kariuppu parpam was done at mettex laboratories of India, 
Guindy, Chennai-32. The tests done are as follows: 
 
1.Loss of drying @ 105˚c : 
 
Five grams of kariuppu parpam is heated in a hot oven at 105˚ c to constant weight. The 
percentage of loss of weight was calculated. 
 
2. Determination of ash value: 
 
Weigh accurately 2-3 grams of kariuppu parpam intarred platinum (or) silica dish and 
incinerate at a temperature not exceeding 450˚c until free from carbon, cool and weigh. Calculate 
the percentage of ash with reference to the air dried drug . 
 
3. Water  soluble ash: 
 
To the Gooch crucible containing to the total ash, add 25 ml of water and boil for 5 
minites. Collect the insoluble matter in a sintered glass crucible or on ash less filter paper.wash 
with hot water and ignite in a crucible for 15 mintes at a temperature not exceeding 450˚c  
substract the weight of the insoluble matter from the weight of the ash the difference of the 
weight represents the water soluble ash. Calculate the percentage of water soluble ash with 
reference to the air dried drug. 
 
4.  Alkalinity as Caco3 in water soluble ash: 
Five grams of kariuppu parpam converted to ash, boiled with water filtered. 
  
 Fitrated was tiltrated against 0.1 N  of Hcl using phenophthaelin as an indicator. 
 
                         Alkalinity of water soluble ash =   X x  of acid / 0.1  x  W 
                                               X   -  Titre value 
W   -  weight of the material taken. 
                       Alkalinity is given as ml of 0.1 N  of Hcl  equated to 1 gm. 
 
5. Acid insoluble ash: 
 
Boil the ash for  5 minutes with 25 ml of 1 : 1  dilute Hcl. Collect the insoluble matter in 
Gooch- crucible on an ash less filter parper wash with hot water and ignite. Cool in a dessicator 
and weigh. Calculate the percentage of acid insoluble ash with reference to the air dried drug. 
 
6. PH at 10 % aqueous solution : 
 
Five grams of Kudasapalai pattai chooranam is weighted accurately and placed in clear 
100 ml  beaker. Then 50 ml of distilled water is added to it and dissolved well. Wait for 30 
minutes and then apply in to PH mater at standard buffer solution of 4.0, 7.0, and 9.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
5 gms of Kudasapalai pattai  Choornam is weighted accurately and placed in clear 
100ml beaker.  Then 50ml of distilled water is added to it and dissolved well.  Wait for 30 
minutes and then apply in pH meter at standard buffer solution of 4.0, 7.0 and 9.2 
 
Sl. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample fine powder  
2. Solubility: 
a.  A little of the sample is shaken 
well with distilled water 
b.  A little of the sample is shaken 
well with con Hcl / con H2So4 
 
Sparingly soluble 
 
InSoluable in Con – 
Hcl / Con Hnco3 
 
 
 
Absence of silicate 
3. Action Of Heat: 
A small amount of the sample is 
taken in a dry test tube and heated 
gently at first and then strongly 
 
No White fumes 
evolved 
 
No brown fumes 
 
Absence of Carbonate 
 
 
Absence of Nitrate 
4. Flame Test: 
A small amount of the sample is 
made in to a paste with con. Hcl in 
a watch glass and introduced into 
non-luminous part of the Bunsen 
flame 
 
No bluish green 
Colour appeared 
 
Absence of Calcium 
5. Ash Test: 
A filter paper is soaked into a 
mixture of sample and add cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited 
 
No Yellow Colour 
flame 
 
Absence of sodium 
 
 
  
 
PREPARATION OF EXTRACT: 
5 gm of Kudasapalai pattai choornam is weighed accurately and placed in a 250 ml 
clean beaker and added with 50ml of distilled water. Then it is boiled well for about 10 minutes.  
Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml with distilled 
water. 
 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
I Test For Acid Radicals   
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube, to 
this, add 2ml of 4% ammonium 
oxalate solution 
 
b. 2 ml of the above prepared 
extract is added with 2ml of dil, 
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution 
is added 
 
Cloudy appearance 
Present 
 
 
 
A white precipitate 
insoluble in con.Hcl 
is  obtained. 
 
Presence of sulphate. 
 
 
 
 
Sulphate is confirmed 
2. Test For Chloride: 
2 ml of the above prepared extract is 
added with dil. HNo3 till the 
effervescence ceases.   Then 2ml of 
silver nitrate solution is added 
 
No cloudy 
appearance Present 
 
Absence of chloride 
  
3. Test For Phosphate: 
2 ml of the extract is treated with 2ml of 
ammonium molybdate solution and 2ml 
of Con. HNO3 
 
No cloudy yellow 
appearance 
 
Absence of phosphate 
4. Test For Carbonate: 
2 ml of the extract is treated with 2ml of 
magnesium sulphate solution 
No Cloudy 
appearance 
Absence of Carbonate 
5. Test For Nitrite: 
1 gm of the substance is heated with 
copper turning and concentrated H2So4 
and viewed the test tube vertically down 
 
No characteristic 
changes 
 
Absence of Nitrate 
6. Test For Sulphide: 
1 gm of the substance is treated with 2 
ml of Con. Hcl 
 
No Rotten egg 
smelling gas evolved 
 
Absence of sulphide` 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil 
acetic acid and 2ml of calcium chloride 
solution and heated 
 
No cloudy 
appearance 
 
Absence of fluoride and 
oxalate 
8. Test For Nitrite: 
3 drops of the extract is placed on a 
filter paper, on that 2 drops of acetic 
acid and 2 drops of benzidine solution is 
placed. 
 
No Characteristic 
changes 
 
Absence of Nitrite 
9. Test For Borate: 
2 pinches of the substance is made into 
paste by using sulphuric acid and alcohol 
(95%) and  introduced into the blue flame 
 
Bluish green colour 
flame appeared 
 
Presence of Borate 
II Test For Basic Radicals 
1. Test For Lead   
  
2 ml of the extract is added with 2ml of 
potassium iodide solution 
No yellow precipitate Absence of lead 
2. Test For Copper 
a. One pinch of substance is made in to 
paste with con. Hcl in a watch glass 
and introduced into the non – 
luminous part of the bunsen flame. 
 
b. 2 ml of extract is added with excess of 
ammonia solution 
 
NoBlue colour  flame 
 
 
 
 
 
No  Blue colour 
precipitate formed 
 
Absence of copper 
 
 
 
 
Abesence of copper 
3. Test For Aluminium: 
To the 2ml of the extract sodium hydroxide is 
added in drops to excess 
 
No characteristic 
changes 
 
Absence of aluminium 
4. Test For Iron. 
a. To the 2ml of extract add 2 ml of 
ammonium thiocyanate solution. 
 
b. To the 2ml of extract add 2ml 
ammonium thiocynate solution and 
2ml of con HNo3 is added 
 
 
No mild red colour 
appeared 
 
 
No Blood red colour 
appeared 
 
Absence of Iron 
 
 
 
Absence of Iron 
5. Test For Zinc 
To 2ml of the extract sodium hydroxide 
solution is added in drops to excess 
white precipitate is 
formed 
Presence of Zinc 
6. Test For Calcium 
2ml of the extract is added with 2ml of 4% 
ammonium oxalate solution 
 
No Cloudy 
appearance white 
precipitate is obtained 
 
Abesence of Calcium 
7. Test For Magnesium 
To 2ml of extract sodium hydroxide solution 
 
White Precipitate is 
 
Presence of 
  
is added in drops to excess obtained Magnesium 
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Test For Ammonium: 
To 2ml of extract few ml of Nessler’s reagent 
and excess of sodium hydroxide solution are 
added 
 
No Brown colour 
appeared 
 
Absence of ammonium 
 
9. 
 
Test For Potassium: 
A pinch of substance is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% glacial acetic 
acid 
 
No Yellowish 
precipitate is obtained 
 
Absence of Potassium 
10. Test For Sodium 
2 Pinches of the substance is made into paste 
by using Hcl and introduced in to the blue 
flame, of Bunsen burner 
 
No Yellow colour 
flame  appeared 
 
Absence of Sodium 
11. Test For Mercury 
2 ml of the extract is treated with 2ml of 
sodium hydroxide solution 
 
No yellow precipitate 
is obtained 
 
Absence of Mercury 
12. Test For Arsenic: 
2ml of extract is treated with 2ml of silver 
nitrate solution 
 
No brownish red 
precipitate is obtained 
 
Absence of Arsenic 
III. Miscellaneous:   
1. Test For Starch: 
2 ml of extract is treated with weak Iodine 
solution 
 
No blue colour 
developed 
 
Absence of starch 
2. Test For Reducing Sugar: 
5 ml of Benedicts qualitative solution is taken 
in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
 
No Brick red colour 
developed 
 
Absence of Reducing 
sugar 
  
changes are noted 
3. Test For The Alkaloids: 
a. 2ml of the extract is treated with 2ml 
of potassium iodide solution. 
b. 2ml of extract is treated with 2ml of 
picric acid. 
2ml of the extract is treated with 2ml of 
phosphotungstic acid 
 
 
No red colour 
developed 
 
Yellow colour 
developed 
White precipitate 
obtained 
 
 
 
 
Presence of alkaloid 
 
4. Test For Tannic Acid: 
2 ml of extract is treated with 2ml of ferric 
chloride solution 
 
Black precipitate 
appeared 
Presence of Tannic acid
5. Test For Unsaturated 
Compound: 
To the 2ml of extract 2ml of potassium 
permanganate solution is added 
 
 
Potassium 
Permanganate is not 
decolourised 
 
 
Absence of unsaturated 
compound 
6. Test For Amino Acid: 
2 drops of the extract is placed on filter paper 
and dried well 
 
Violet colour 
developed 
 
Presence of amino 
acids 
7. Test for Type of Compound 
2 ml of the extract is treated with 2 ml of 
ferric chloride solution 
 
No green colour 
developed 
 
No Red colour 
developed 
 
No violet colour 
developed 
 
No Blue colour 
 
Absence of oxy quinole 
epineplhrine and phro 
catechol 
Anti pyrine, Aliphatic 
amino acids and 
meconic acid are absent
Apomorphine salicylate 
and resorcinol are 
absent 
 
  
developed Morphine, phenol 
cresol and hydro 
quinine are absent 
 
 
 
EFFECT OF KUDASA PALAI PATTAI CHOORANAM AGAINST 
HISTAMINE IN ISOLATED GUINEA PIG ILEUM 
 
 
Animals: Adult guinea pig (400-600 gms) obtained from King Institute, Chennai were used for 
the experiment. 
 
Drugs: Histamine acid phosphate (1mg/ml), Kudasapalai pattai chooranam (1mg/ml)  was 
used. 
 
Test drug preparation: 
The test drug concentration was 100microgram per ml prepared by dissolving with 2% 
CMC in distilled water. 
 
MATERIALS AND METHODS 
 
Preparation of guinea pig ileum 
Adult guinea pig was stunned and bled. Segments of the ileum (4 cm long) were removed 
10 cm from the caecum, and treated as in the case of stomach strip. The strip was incubated for 
30 min before constructing concentration-response curves to the test drug. The pH of the stock 
  
solution, before adding to the organ bath, and when in the bath was measured. Contact time of 
drug or standard agonist with the tissue was maintained at 5 min intervals. 
 
 
 
       ANTIINFLAMMATORY ACTIVITY OF KUDASA PALAI PATTAI CHOORANAM 
            PROCEDURE 
 
 
Anti-inflammatory activity was studied by formalin-induced rat hind paw edema, 
measured by plethysmograph  (mercury displacement method). Wistar strain rats of either sex 
weighing between 150- 200 g were divided into three groups of six animals each. The first group 
served as the control and received the vehicle i.e. 2% CMC, second group of animals were 
administered with standard drug diclofenac sodium, 45-mg/kg-body weight. The third group of 
animals was treated with Kudasapalai pattai chooranam at a dose of 400-mg/kg body weight, 
orally. The volume of paw edema was measured in control, standard and treated groups 
accordingly at every fifteen minutes once for 2hours and finally at 24th h after formalin injection. 
The percent inhibition of edema was calculated. The data were analyzed by one-way ANOVA. 
According to this test, there was a significant difference between the drug treated groups and 
control at the level of P<0.05. 
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DEFINITION: 
Eczema –  “ Boil out ’’ 
Dermatitis and eczema is non – contagious inflammation of the skin characterized by erythema, 
scaling, oedema, vesiculation and oozing. 
 
Eczema is a specific type of allergic cutaneous manifestation of antigen –antibody reaction. It is 
characterized by superficial inflammatory oedema of the epidermis associated with vesicle 
formation itching various from mild to severe paroxysms which even interfere with  work and 
sleep . 
 
ETIOLOGY: 
Two factors causes dermatitis and eczema – 
1.Allergic (or) a sensitive skin 
2. Exposure to an irritant 
*Darier has correctly said that 
            “  There is no eczema but an eczematous patient ” 
 
GENERAL CAUSES: 
* Age 
* Familial predisposition 
* Allergy, debility, climate (Heat , severe cold) 
* Eczema sometimes occurs in infancy, at puberty and at the time 
of menopause 
  
* Familial sensitiveness, Familial history of allergy (Asthma, eczema) 
 
PHOTODERMATITIS : 
 
In this condition is confined to the exposed parts of the body (Face, neck, ‘v’ of the chest , hands, 
external surfaces of the forearm and dorsam of feet, adjoining parts of legs. 
Integument is sensitive to sun light and ultra- violet rays. 
 
PHYTO-PHOTO DERMATITIS: 
 
It means photo sensitization of the skin after contact with plants. Which have either phyto 
(or) photo- allergic action. 
 
CONTACT  DERMATITIS : 
 
Synonym: Chemical eczema. 
Contact dermatitis develops with in a few hours after contact with the    offending agent. 
• The eruption develops briskly, spreading for beyond the original point of contact. 
• It has ill- defined margin 
• Fading at the periphery. 
• Brisk edema and uniform vesiculation 
CAUSES: 
• Plants, clothing and foot wear 
• Cosmetics 
• Occupational chemicals, Medication. 
 
INFECTIOUS ECZEMATOID DERMATITIS : 
Synonym- Infective eczema 
This results from sensitization to certain organism  like Streptococci, Staphylococci, 
Dermatophytes and yeast organisms. 
 
  
CHARACTERS: 
• Slow development 
• No vesiculation 
• Crust is formed instead 
• Patches are sharply defined 
• No erythematous halo. 
 
ENDOGENOUS ECZEMA: 
 
There is no evidence of external irritants (or) allergens in endogenous eczema. Parts of 
the body become sensitized internal body products-toxins from focal sepsis, metabolites. 
 
INFANTILE ECZEMA: 
 
This occurs in children between the ages of three months and two years. It usually starts on the  
cheeks, then forehead, chin, sclap, arms, trunk and legs, on the buttocks and in thegroins napkin 
like dermatitis may develop. 
 
  ATOPIC ECZEMA: 
 
Synonym- Besinier’s pururigo 
It is also called  Asthma-Eczema syndrome. There is a strong familial predisposition to allergic 
diseases like asthma, eczema and hay fever. 
Frequency a personal history of collateral allergies is present. 
 
NUMMULAR ECZEMA: 
 
Synonym: Discoid eczema 
It is characterized by circular coin- shaped plaques of papules, vesicles and crusting, distributed 
bilaterally and symmentrically on the dorsam of fingers the hands, the forearms, the arms, the 
legs and thighs. 
  
 
DISSEMINATED ECZEMA: 
 
Synonym- Eczematides. 
Tiny popular, vesicular and occasionally bullous crusted lesions occuring singly (or) in small 
patches resulting from sensitization to the products of primary active eczema being conveyed by 
the blood srream to distant sites producing dissemination of the eczematous process. This 
process is called “Auto –sensitization ” . 
 
NEURO DERMATITIS: 
 
Synonym- Lichen simplex chronicus. 
Affecting commonly neurotic people. This  condition may be defined as the Lichenification  
process resulting from chronic scratching and rubbing of the skin under stress and anxiety. 
 
VARICOSE DERMATITIS  (OR) ECZEMA: 
 
This is simply traumatic, chemical (or) infective eczema. Complicating varicose veins (or) ulcers 
of the legs. The predisposing factors are chronic congestion and stasis which lower the local 
resistance. 
 
RADIO- DERMATITIS : 
It implies dermatitis produced by excessive doses of x-rays received by the skin . 
 
DERMATITIS MEDICAMENTOSA: 
It comprises  all cutaneous eruptions  resulting from the internal use of drugs. 
 
DERMATITIS AUTOPHYTICA: 
Synonym- Dermatitis brought on with strong physical agents (or) acids by hysterical individuals. 
 
DYSHIDROSIS: 
  
Synonym- Cheiropompholyx 
It consist of bilaterlly  symmentrical eruption affecting the palms of hands and less frequently, 
the sides and soles of feet. Leision consist of deeply set vesicles. 
 
 
 
 
CLINICAL  STUDY 
 
SELECTION OF PATIENTS: 
                     30 Patients  of both sexes were selected from the out patient 
Department of Nationl institute of siddha, Chennai-47. By present inclusion and exclusion 
criteria. 
 
CRITERIA FOR SELECTION: 
Inclusion criteria: 
1. Age 25- 60 years 
2. Willing to be admitted in the hospital for 48 days (or) willing to 
attend OPD once in 12 days for 48  days. 
Exclusion criteria: 
1. Varicose , Hay fever 
2. Urticaria 
3. Infantile eczema 
4. Diabetic dermatitis 
5.  Neuro dermatitis. 
WITHDRAWAL CRITERIA 
Increase in itching, incidence of constipation, other acute illness during trial  period. 
LINE OF TREATMENT: 
The drug kudasapalai pattai choornam was administrated internally in dose of   1 gm three 
times a day with the vehicle water after diet. 
  
DIET RESTRICTION: 
Patient were advised to avoid : 
1. Brinjal 
2. Sea foods 
3. Agathi, paagal, poosani 
RESULTS AND OBSERVATION 
 
RESULTS OF BIOCHEMICAL ANALYSIS 
 
The given sample contains 
 
• Sulphate 
• Zinc 
• Borate 
• Calcium 
• Magnesium 
• Tannic Acid 
• Amino acid 
• Alcoloid 
 
RESULTS OF STANDARDISATION PARAMETERS : 
 
1. Loss on drying     0.52 
2. Total ash  value     5.70 
3. Water soluble Ash    12.03 
4. Alkalinity as CaCo3  in water soluble Ash     0.21 
5. Acid insoluble Ash    1.54 
6. PH at 10% aqueous solution     6.80 
 
  
 
 
 
 
 
 
          RESULTS  OF KUDASA PALAI PATTAI CHOORANAM AGAINST 
 
          HISTAMINE IN ISOLATED GUINEA PIG ILEUM 
 
 
The pH of the drug solution before adding to the organ bath, and in the organ bath remained at 
7.0. The Kudasapalai pattai chooranam had a moderate antagonistic effect against histamine 
on guinea pig ileum. The contractile response was concentration- dependent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
ANTI INFLAMMATORY ACTIVITY OF KUDASAPALAI PATTAI CHOORANAM 
RESULT 
At 1h, Diclofenac exhibited good anti-inflammatory activity compared to control group 
(Table 1), Where as at 2 h, anti-inflammatory activity of kppc was statistically different. It 
means, diclofenac showed highest anti-inflammatory activity followed by Kudasapalai pattai 
chooranam. Hence, the results of the present investigation conclude that the Kudasapalai pattai 
chooranam is accountable for the moderate anti-inflammatory (20.88%) activity. 
 
TABLE-1-ANTIINFLAMMATORY ACTIVITY OF KUDASAPALAI PATTAI 
CHOORANAM 
S.No Treatment Dose (mg/kg) Mean increase in paw 
volume(ml) 
Percentage 
inhibition 
1 Control 2ml/kg 0.742±0.061 --- 
2 Diclofenac sodium 45mg/kg 0.329±0.053** 55.66 
3 Kppc 400mg/kg 0.587±0.052* 20.88 
**P values <0.01; *P<0.05 as compared to control 
 
  
 
RESULTS OF CLINICAL ASSESSMENT 
 
       TABLE:2     AGE WISE  DISTRIBUTION 
 
 
 
 
 
 
 
 
. 
 
 
S.No 
 
AGE 
 
PERCENTAGE 
 
1. 20-30 years  10% 
2. 30-40 years  30% 
3. 40-50 years  23.33% 
4. 50-60 years 36.66% 
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For the clinical study of kudasapalai pattai chooranam in karappan. 30 patients were selected. 
According to age wise distribution 10% were in 20-30 yrs, 30% were in 30-40 yrs, 23.33% were 
in 40-50 yrs, 36.66% were in 50-60 yrs. 
 
 
TABLE:3   SEX  WISE DISTRIBUTION 
 
 
 
S.No 
 
 
SEX 
 
PERCENTAGE 
 
1. 
 
Female 
 
40% 
 
 
2. 
 
Male 
 
60% 
 
 
 
 
 
  
SEX DISTRIBUTION
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According to sex wise distribution 40% were in female , 60% were in male. 
 
 
 
 
                              
                                 RESULTS OF STATISTICAL ANALYSIS 
 
 
 
                Improvement showing signs and symptoms before and after treatment 
 
                   TABLE:4 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
Symptoms 
No.of patients with 
Symptoms 
 
 
Percentage Before 
Treatment 
 
After 
Treatment 
1. Hyper 
Pigmentation 
30 1 96.67% 
2. Pruritis 28 2 92.86% 
3. Swelling 11 1 90.91% 
4. Erythema 18 1 94.44% 
5. Oozing 24 2 91.67% 
6. Macules 24 2 91.67% 
7. Papules 12 1 91.67% 
8. 
 
Vesicles 10 1 90% 
  
 
 
 
From  the clinical study 96.67% of patients get relieved from Hyper pigmentation, 92.86% get 
relieved from  Pruritis, 90.91% patients get relieved from Swelling, 94.44% patients get relieved 
from Erythema, 91.67% patients get relieved from Oozing , 91.67% patients get relieved from 
Macules, 91.67% get relieved from Papules,90% patients get relieved from Vesicles and no 
adverse effects were observed. 
From the cliical and stastical analysis, it is proved  that the drug kudasapalai pattai chooranam is 
staistically  significant. 
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                                                          KARAPPAN ( ECZEMA ) - BLOOD  INVESTIGATION – BEFORE TREATMENT     
 
 
 
 
 
 
 
S.No 
 
OP/IP No 
 
   Hb  
  gm% 
 
 
       TC 
     Cells/ 
    cu.mm 
         
                      DC 
    
  ESR 
 
Blood 
Sugar 
 (R) 
mg/dl 
 
 
Urea 
Mg% 
 
 
Crea 
Mg% 
 
 
 
CHO 
Mg% 
           
                URINE 
 
P% 
 
L% 
 
E% 
 
M% 
 
½ hr 
mm 
 
1hr 
mm 
 
Alb 
 
Sug 
     Deposit 
Pus 
Cells 
Epi 
Cells 
1 AG3120 16.6 6400 55 40 3 2 2 4 140 22 0.8 175 Nil Nil 3-6 2-4 
2 AG2904 14.5 8600 55 38 5 2 6 12 80 27 0.8 207 Nil Nil 1-2 3-4 
3 AG2910 12.6 7300 50 42 7 1 6 12 92 21 0.8 252 Nil Nil 3-4 3-4 
4 AG2978 13.5 6800 50 43 7 - 15 32 128 22 0.8 200 Nil Nil 6-8 1-2 
5 AG4159 14.5 6200 52 46 2 - 6 12 68 17 0.7 100 Nil Nil 3-4 1-2 
6 AG4883 12 7600 55 41 4 - 12 25 80 16 0.8 179 Nil Nil 4-6 2-4 
7 AG5163 10.7 5600 50 47 3 - 3 6 86 14 0.5 156 Nil Nil 2-4 4-6 
8 786 1 8800 60 38 2 - 5 10 61 23 0.5 159 Nil Nil 2-3 1-2 
9 AG5566 12.1 6700 52 44 4 - 12 26 93 15 0.8 140 Nil Nil 1-2 1-2 
10 AF2356 16 6100 50 47 3   - 10 20 88 22 0.8 170 Nil Nil 2-4 2-4 
11 AG9148 13.1 7900 50 45 5 - 2 4 60 13 0.6 160 Nil Nil 1-2 1-2 
12 AG2620 12.6 6200 50 47 2 1 6 15 80 30 0.8 132 Nil Nil 1-2 1-2 
13 AG9267 12.6 7900 54 40 4 - 4 8 74 13 0.8 178 Nil Nil 1-2 1-2 
14 AG9262 11 5600 50 48 2 - 6 15 99 18 0.5 175 Nil Nil 3-4 1-2 
15 AG9366 7.8 6000 60 38 2 - 10 24 84 23 0.6 163 Nil Nil 2-3 2-3 
16 AF3826 13.5 8100 61 34 5 - 4 8 97 31 0.6 200 Nil Nil 3-5 0-1 
17 AH522 10.6 6800 55 42 3 - 1 8 118 18 0.6 172 Nil Nil 2-3 1-2 
18 AH1910 11 6300 50 45 3 2 7 20 135 18 0.5 130 Nil Nil 2-3 2-3 
19 AH2068 12.4 7000 59 38 3 - 6 12 144 19 0.5 229 Nil Nil 2-3 2-3 
20 AH4771 10.7 5500 50 42 3 - 6 12 128 24 0.7 185 Nil Nil 1-2 2-3 
21 A1245 14 8500 59 38 3 - 6 12 109 21 0.6 187 Nil Nil 2-4 1-2 
22 AH6698 14.1 6200 52 45 3 - 4 8 103 18 0.4 162 Nil Nil 0-1 2-3 
23 AH6868 12.6 7800 60 35 5 2 10 20 91 31 0.8 135 Nil Nil 0-1 2-3 
24 AH8061 11.2 6200 50 45 3 2 11 22 98 25 0.9 178 Nil Nil 3-4 2-3 
25 AH7933 15 6800 55 40 3 2 2 4 71 24 0.7 207 Nil Nil 3-4 1-2 
26 AH8422 12 7300 55 40 3 2 3 4 80 24 0.8 178 Nil Nil 1-2 2-4 
27 AH8473 13.5 7900 54 41 5 - 12 24 86 21 0.7 176 Nil Nil 2-4 4-6 
28 AC5366 12.1 6200 55 42 3 - 5 10 125 18 0.6 167 Nil Nil 3-4 2-3 
29 AG3420 13.1 9600 50 41 7 - 5 11 119 30 0.5 180 Nil Nil 1-2 0-1 
30  AG2671 12.5 7600 57 37 6 - 19 38 117 34 0.7 170 Nil Nil 2-3 2-4 

  
KARAPPAN (ECZEMA) - BLOOD  INVESTIGATION – AFTER TREATMENT     
                      
 
 
 
 
S.No 
 
OP/IP No 
 
   Hb  
  gm% 
 
 
       TC 
     Cells/ 
    cu.mm 
         
                      DC 
    
  ESR 
 
Blood 
Sugar 
 (R) 
mg/dl 
 
 
Urea 
Mg% 
 
 
Crea 
Mg% 
 
 
 
CHO 
Mg% 
           
                URINE 
 
P% 
 
L% 
 
E% 
 
M% 
 
½ hr 
mm 
 
1hr 
mm 
 
Alb 
 
Sug 
     Deposit 
Pus 
Cells 
Epi 
Cells 
1 AG3120 14 6,800 50 46 04 - 4 8 94 18 0.6 161 Nil Nil 6-8 1-2 
2 AG2904 10.5 7,200 53 42 005 - 6 12 101 18 0.6 156 Nil Nil 3-5 1-2 
3 AG2910 12.4 8,900 50 46 04 - 4 8 110 28 0.6 190 Nil Nil 6-8 1-6 
4 AG2978 12.8 7,900 54 43 03 - 12 23 98 22 0.7 185 Nil Nil 1-2 2-3 
5 AG4159 13.2 7,000 58 37 05 - 6 80 86 12 0.8 172 Nil Nil 1-2 1-2 
6 AG4883 11 6,400 50 44 04 02 11 22 105 14 0.8 186 Nil Nil 2-4 4-6 
7 AG5163 12 7,000 53 42 04 01 6 12 121 14 0.8 170 Nil Nil 2-4 2-4 
8 786 13.7 7,800 58 40 02 - 2 4 102 21 0.8 184 Nil Nil 2-3 1-2 
9 AG5566 13.4 8,100 60 38 02 - 4 8 105 16 0.8 164 Nil Nil 1-2 2-3 
10 AF2356 9.1 6,800 53 42 05 - 34 70 93 35 1.3 200 Nil Nil 2-4 2-4 
11 AG9148 12.8 6,900 54 42 04 - 4 8 89 26 0.6 200 Nil Nil 1-2 1-2 
12 AG2620 12.4 7,400 54 42 02 02 6 12 88 22 0.8 180 Nil Nil 1-2 1-2 
13 AG9267 10.6 7,800 52 46 02 - 4 8 111 28 0.8 180 Nil Nil 1-2 1-2 
14 AG9262 14 7,200 60 38 02 - 2 4 104 30 0.8 175 Nil Nil 3-4 1-2 
15 AG9366 12 7,400 54 42 04 - 4 8 99 24 0.6 168 Nil Nil 2-3 2-3 
16 AF3826 13.6 8,000 50 46 03 01 12 24 110 30 0.8 170 Nil Nil 1-3 1-2 
17 AH522 14.5 8,000 54 42 04 - 4 8 89 26 0.8 180 Nil Nil 2-3 1-2 
18 AH1910 11 6,700 53 43 02 - 4 12 87 22 0.6 140 Nil Nil 2-3 1-2 
19 AH2068 12.6 6,900 50 44 06 - 6 4 94 16 0.6 146 Nil Nil 6-8 1-2 
20 AH4771 11.6 7,600 60 32 08 - 2 12 103 22 1.1 152 Nil Nil 1-2 2-3 
21 A1245 12.6 7,800 57 38 06 - 6 12 122 28 0.6 151 Nil Nil 2-4 1-2 
22 AH6698 10.5 6,800 50 42 08 - 6 14 112 24 0.8 160 Nil Nil 2-4 2-4 
23 AH6868 12.6 7,900 54 41 03 02 40 10 107 23 0.8 222 Nil Nil 2-3 1-2 
24 AH8061 10 8,400 54 44 02 - 4 24 114 16 0.8 176 Nil Nil 1-2 1-2 
25 AH7933 10.6 7,000 48 48 04 - 12 12 96 14 0.6 170 Nil Nil 3-4 2-3 
26 AH8422 12.4 8,900 50 46 04 - 64 8 100 28 1.0 184 Nil Nil 2-3 2-4 
27 AH8473 14.5 8,.000 54 40 04 - 6 12 102 24 0.8 170 Nil Nil 2-4 4-6 
28 AC5366 12.8 6,700 53 42 05 - 4 8 87 18 1.2 146 Nil Nil 3-4 2-3 
29 AG3420 13.5 7,200 51 47 02 - 6 12 93 33 0.8 160 Nil Nil 1-2 0-1 
30  AG2671 13 6,000 52 44 04 - 12 24 105 18 0.6 173 Nil Nil 2-3 2-4 
  
                                                           KARAPPAN (ECZEMA) - IMPROVEMENT REPORT 
 
 
 
S.
N 
 
OP/IP     
   No 
 
Age 
 
Hp 
BT 
 
Hp 
AT 
 
Pr 
BT 
 
Pr 
AT 
 
Sw 
BT 
 
Sw 
AT 
 
Er 
BT 
 
Er 
AT 
 
Cr 
BT 
 
Cr 
AT 
 
Oo 
BT 
 
Oo 
AT 
 
Ma 
BT 
 
Ma 
AT 
 
Pa 
BT 
 
Pa 
AT 
 
Ve 
BT 
 
 
Ve 
AT 
 
Pu 
BT 
 
Pu 
AT 
  
* Hp – Hyper  Pigmentation  * Pr – Pruritis * Sw – Swelling * Er – Erythema  * Cr – Crusting  * Oo – Oozing * Ma – Macules * Pa – Papules *Ve – Vesicles  
* Pu – Pustules 
1 AG3120 M + - + - - - - - - - + - + - - - - - - - 
2 AG2904 M + - + - - - - - - - + - + - - - - - - - 
3 AG2910 M + - + - - - + - - - + - + - - - + - - - 
4 AG2978 F + - + - + - - - - - + - + - - - - - - - 
5 AG4159 M + - + - - - + - - - + - + - - - - - - - 
6 AG4883 F + - + - - - - - - - + - - - + - - - - - 
7 AG5163 F + - + - - - + - - - - - + - - - - - - - 
8 786 M + - + - + - - - - - - - + - + - - - - - 
9 AG5566 F + - + - - - + - - - + - - - + - - - - - 
10 AF2356 M + - - - - - + - - - + - + - - - - - - - 
11 AG9148 M + - + - - - - - - - + - + - - - + - - - 
12 AG2620 M + - - - + - + - - - + - + - - - - - - - 
13 AG9267 F + - + - - - - - - - + - - - - - + - - - 
14 AG9262 M + - + - + + + + - - + - + - + - - - - - 
15 AG9366 F + - + - + - - - - - + - - - - - + - - - 
16 AF3826 M + - + - - - + - - - + - + - - - + - - - 
17 AH522 M + + + + + - + - - - + + - - - - - - - - 
18 AH1910 F + - + - - - + - - - + - + - + - - - - - 
19 AH2068 M + - + - - - - - - - + - + - + - + - - - 
20 AH4771 M + - + - - - + - - - - - + - - - + - - - 
21 A1245 F + - + - + - - - - - + - + - + - + - - - 
22 AH6698 M + - + - - - - - - - - - - - - - - - - - 
23 AH6868 F + - + - - - + - - - - - + - + - + - - - 
24 AH8061 F + - + - + - + - - - + - + - + - - - - - 
25 AH7933 F + - + - + - + - - - - - + - - - - - - - 
26 AH8422 F + - + - - - - - - - + - + - + - + + - - 
27 AH8473 M + - + + + - + - - - + + + + + + - - - - 
28 AC5366 M + - + - - - + - - - + - + - + - - - - - 
29 AG3420 M + - + - + - + - - - + - + - - - - - - - 
30 AG2671 M + - + - + - + - - - + - + + - - - - - - 
 
S.
N 
 
OP/IP     
   No 
 
Age 
 
Hp 
BT 
 
Hp 
AT 
 
Pr 
BT 
 
Pr 
AT 
 
Sw 
BT 
 
Sw 
AT 
 
Er 
BT 
 
Er 
AT 
 
Cr 
BT 
 
Cr 
AT 
 
Oo 
BT 
 
Oo 
AT 
 
Ma 
BT 
 
Ma 
AT 
 
Pa 
BT 
 
Pa 
AT 
 
Ve 
BT 
 
 
Ve 
AT 
 
Pu 
BT 
 
Pu 
AT 
1 AG3120 M + - + - - - - - - - + - + - - - - - - - 
2 AG2904 M + - + - - - - - - - + - + - - - - - - - 
3 AG2910 M + - + - - - + - - - + - + - - - + - - - 
4 AG2978 F + - + - + - - - - - + - + - - - - - - - 
5 AG4159 M + - + - - - + - - - + - + - - - - - - - 
6 AG4883 F + - + - - - - - - - + - - - + - - - - - 
  
                             
7 AG5163 F + - + - - - + - - - - - + - - - - - - - 
8 786 M + - + - + - - - - - - - + - + - - - - - 
9 AG5566 F + - + - - - + - - - + - - - + - - - - - 
10 AF2356 M + - - - - - + - - - + - + - - - - - - - 
11 AG9148 M + - + - - - - - - - + - + - - - + - - - 
12 AG2620 M + - - - + - + - - - + - + - - - - - - - 
13 AG9267 F + - + - - - - - - - + - - - - - + - - - 
14 AG9262 M + - + - + + + + - - + - + - + - - - - - 
15 AG9366 F + - + - + - - - - - + - - - - - + - - - 
16 AF3826 M + - + - - - + - - - + - + - - - + - - - 
17 AH522 M + + + + + - + - - - + + - - - - - - - - 
18 AH1910 F + - + - - - + - - - + - + - + - - - - - 
19 AH2068 M + - + - - - - - - - + - + - + - + - - - 
20 AH4771 M + - + - - - + - - - - - + - - - + - - - 
21 A1245 F + - + - + - - - - - + - + - + - + - - - 
22 AH6698 M + - + - - - - - - - - - - - - - - - - - 
23 AH6868 F + - + - - - + - - - - - + - + - + - - - 
24 AH8061 F + - + - + - + - - - + - + - + - - - - - 
25 AH7933 F + - + - + - + - - - - - + - - - - - - - 
26 AH8422 F + - + - - - - - - - + - + - + - + + - - 
27 AH8473 M + - + + + - + - - - + + + + + + - - - - 
28 AC5366 M + - + - - - + - - - + - + - + - - - - - 
29 AG3420 M + - + - + - + - - - + - + - - - - - - - 
30 AG2671 M + - + - + - + - - - + - + + - - - - - - 
  
DISCUSSION 
 
The drug  kudasapalai  pattai chooranam was selected to find its efficacy in the 
management of karappan(Eczema). 
The literary evidence from the text, Gunapadam-Mooligai vaguppu  strongly   support the anti-
histaminic, anti- inflammatory activity of the drug. 
Bio-chemical analysis of the drug kudasapalai pattai chooranam reveals the presence of sulphate,   
borate, , magnesium, zinc, calcium, tannic acid, amino acid, alkaloid. 
 
SULPHATE: 
Sulphates  are the salts of sulfur. Sulfur is known as healing mineral. It aids every cell in the 
determination of toxic substances through agitation. Sulfur aids functions in enzyme reactions 
and protein synthesis and is important in cellular respiration. 
 
ZINC: 
Zinc helps in the function of enzyme superoxide dimutase(SOD), Which is an Anti- oxidant. 
Thus it cures eczema  by scavenging free radicals. 
 
BORATE: 
Borates are the salt of boron. Boron is a dynamic trace element that can affect the metabolism or 
ulilization of numerous substances involved in life processes including calcium, copper, 
magnesium, nitrogen, glucose, triglyceride, reactive oxygen and estrogen(Nilesen, 1987). 
 
CALCIUM: 
Calcium is essential to the health of the skin, a lack of which will cause welts, eczema and sores, 
cracks in the skin. Calcium lactate, a salt of calcium helps in preventing eczema. 
 
MAGNESIUM: 
Magnesium is necessary for calcium and vitamin c metabolism. When combined with calcium, 
acts, as a natural tranqilizer, It is called as “Anti-stress” mineral. It improves the blood 
  
circulation and keeps the skin healthy and glowing. One of the causes of eczema is ‘Mental 
stress’. Magnesium gives relief from mental stress. Thus it cures eczema. 
 
TANNIC ACID: 
The properties of tannic acid are Anti- dermatotic, Anti- septic,and Anti- ulcer properties. 
Thus it works well in eczema and other skin infections. 
 
ALBUMIN: 
Albumin is a major source of sulphydryl grops, these “Thiols” scavenge free  radicals (nitrogen 
and oxygen species). Albumin may be an important free radical scavenger in sepsis. 
 
PHENOLIC COMPOUNDS: 
It has very good anti- inflammatory properties. It is often used in arthritis  and other 
inflammatory  disorders. 
 
PROTEINS: 
Proteins are the building blocks of human body, organs, tendons, muscles, nail, hair, skin, glands 
are made up of proteins. Proteins are essential for normal keratinization mechanism of skin and 
for maintaining of texture of normal skin. Its deficiency may causes scaling, peelingand dryness 
of the skin. 
THE PHARMACOLOGICAL STUDIES SHOWS THAT, 
In acute anti- inflammatory study, the drug kudasapalai pattai chooranam has significant anti- 
inflammatory activity at the dose of 50 mg/kg. It is proved that the test drug controls the volume 
of oedema induced from 0 hr to 9th hr. 
Also the values from 1st – 9th  hr are statistically significant, it is mentioned in the table no: 1. 
In anti- histaminic study, the drug kudasapalai pattai chooranam significantly inhibited the activity of histamine. 
 
 
 
 
SIDDHA ASPECT: 
  
      According to Siddha aspect , the drug kudasapalai pattai choornam is thuvarppu suvai& siru 
kaippu suvai. According to Siddha pathology naadi nadai of karappan is Iyya nadi& Vathathil 
ushnam , thuvarppu suvai regulates Iyya thathu. 
It is mentioned as, 
                                           “uikOlzqm<miz<!lKvl<!HtqBh<H!
OskLxs<!osb<Bl<!sqjxbl<!Ykg<Ogt<!
!!!givf<!Kui<gsh<Hg<!gim<Ml<!Sjuobz<zil<!
!!!!!!!!!!!!!!!!!!!!sivh<!hiqgivR<!six<X”/!
 
Kudasapalai pattai choornam contains siru kaippu suvai. Kaippu suvai causes elevation of pitha 
thathu. The pitha thathu inturn regulates iyyam . It is understood, that the kudasapalai pattai 
choornam regulates the Vatha& kaba kutram and is indicated for karappan. Thus it can be given 
in the management of karappan. 
 
CLINICAL ASSESSMENT: 
 
For the clinical study of kudasapalai pattai chooranam in karappan. 30 patients were selected. 
 
According to age wise distribution 10% were in 20-30 yrs, 30% were in 30-40 yrs, 23.33% were 
in 40-50 yrs, 36.66 were in 50-60 yrs. 
According to sex wise distribution 40% were in female , 60% were in male. 
 
From  the clinical study 96.67% of patients get relieved from Hyper pigmentation, 92.86% get 
relieved from Pruritis, 90.91% patients get relieved from Swelling, 94.44% patients get relieved 
from Erythema, 91.67% patients get relieved from Oozing , 91.67% patients get relieved from 
loss of Macules, 91.67% get relieved from Papules, 90% patients get relieved  from vesicles and 
no adverse effects were observed. 
 
From the clinical and stastical analysis, it is proved  that the drug kudasapalai pattai chooranam 
is staistically  significant. 
 
  
SUMMARY 
 
 
 
The drug Kudasapalai Pattai Chooranam  has been selected for this study to evaluate 
its efficacy in the management of “Karappan”. 
 
The litery evidence strongly supports the anti-histaminic and anti- inflammatory  activity of 
kudasapalai pattai chooranam  in the management of “Karappan”. 
Bio-chemical analysis of the drug reveals the presence of sulphate, Borate, zinc, calcium, 
magnesium, Tannic acid ,Amino acid  and alkaloid. 
. 
The pharmacological study shows that the drug has  anti-inflammatory  activity it effectively 
reduced the volume of induced  oedema. 
In anti- histaminic study, the test drug Kudasapalai Pattai Chooranam significantly inhibited 
the activity of histamine. 
 
 
 
CONCLUSION 
 
From the pharmacological studies, literature evidences and based on the observation of their 
study, it is conclude that the drug Kudasapalai pattai chooranam  has significant   Anti- 
inflammatory activity and anti- histaminic activity. Thus it gives us a new hope in the 
management of Karappan. 
 
 
 
 
 
 
  
INTRODUCTION 
 
Siddha system of medicine is an ancient, unique and potent system among all traditional  
system of medicine existing at present. 
 
Man is much more easily subject to diseases than animals in a state of liberty.  It is nature that 
causes diseases and again. It is nature that affects their cure. It had long been recognized that the 
risk of developing disease in man due to the fluctuations in the pattern of health which depends 
on environmental changes like social and economical conditions. Life style modifications 
alteration in the provision of food and water and etc. An individual behaviour relating the 
deliberate use of smoking, alcohol and consumption of tea and coffee. 
 
Man should be the measure of all since the natural conditions of existence have been destroyed by modern civilization, the necessary of all 
sciences. 
 
Gunmam (peptic ulcer) is a more common disease in the world. About 10% of the adults are 
getting affected by this disease at some times in their life. According to the siddha pathology, 
Gunmam is caused due to derangement of vatha, pitha. Though vatha & pitha derangements are 
mentioned as aetiology for Gunmam. Predominantly vatha derangement is the main cause for 
Gunmam. 
This is understood from the text, 
           “okimIuik!hf<klziK!
Ge<ll<!uviK”!!!!!!!!
.!Okve<!
The formulations in siddha medicine include the herbal 
products, in organic substances and animal products and lead to different formulations. Under 
siddha system minerals play a major role. 
In siddha system the minerals are classified as metals – 11, 
salts – 25,      pashanas – 64, Uparasas – 120. 
 
 
 
  
Of these salts (kara – sarum) are less toxic and more safety merely most of the salts are the 
constituents of human physiology. These salts have properties of five elements with themselves. 
So they can be given to the diseases caused due to derangements of three humours.      Salt plays 
an important role in day to day life. Kariuppu (or) common salt (or) sodium chloride is also 
present in serum of human blood 
 
Indigenous system of medicine to find out a more accepted drug for chronic diseases and 
minimal unwanted side effects of the drugs. 
 
In that way I have selected the drug kariuppu parpam for Gunmam (Anti –ulcer activity). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
AIM AND OBJECTIVE 
 
AIM: 
 
To evaluate the Anti-ulcer action and efficacy of kariuppu parpam for the treatment of Gunmam. 
 
OBJECTIVE: 
 
To main objective of the present study is to highlight the efficacy of the drug through. 
 
1. Collection of various literature 
2. Bio- chemical analysis 
3. Physical properties 
4. Acute toxicity 
5. Pharmacological study 
6. Clinical study. 
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                                   BOTANICAL ASPECT 
 
AEGLE MARMELOS ( Linn) Correa ex Roxb. 
                                                                             13 
According to Bentham Hooker classification 
Aegle marmelos :- 
 
Kingdom         :       Plant kingdom 
Division          :       Phanerograms 
Sub division    :      Angiosperms 
Class               :       Dicotyledons 
Sub class         :       Poly petalae 
Series              :       Disciflorae 
Order              :        Geraniales 
Family           :        Rutaceae 
Genus             :        Aegle 
Species          :        Marmelos. 
 
Vernacular Names:17 
Tamil             :        Vilvam 
English          :        Bael (tree) Holy fruit tree. 
Sanskrit         :        Bilva 
Hindi             :        Bel 
 
Family :      Rutaceae. 
 
Habitat : 
Growing wild throughout the deciduous forest in India. Asending to an altitude of 1200m in the 
western Himalayas. 
 
Parts used :          Leaves, fruits, root bark. 
  
 
Chemical constituents: 
Marmesin, Marmin, imperatorin, Coumarin, skimmin, Psoralen, Beta-sitosterol and glycosides 
are also present. 
 
Active priciples and uses : 
 
Fresh leaves yield essential oil containing alpha and beta-phellandrene, rutin and marmesinin. 
 
• Leaves, Roots and bark were found to containing reducing sugar. 
• Fresh leaves yield in distillation a yellowish green oil with a peculiar aromatic odour 
marmelosin. 
• The Aegle is also used in diabetes. The juice of leaves with black pepper ( Piper 
nigrum) is prescribed by herbal practitioners. 
• The active principle in aqueous leaf extract shows activity similar to insulin. 
• Aqueous and alcoholic extract of the leaves are reported to possess cardiotonic effect 
on amphibian and mannalian hearts. 
• Aegle has been credited with digestive and astringent properties. 
 
Astringent leaves are being tried for treating peptic ulcer as the drug is an established 
are for treating diarrhoea and dysentery and is capable of reducing irritation in the 
digestive tract. 
 
 
 
 
 
 
 
 
KARIUPPU IN  GUNAPADAM  ASPECT 
 
(SODIUM CHLORIDE) 
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CHEMICAL ASPECT 
 
CHEMICAL NAME    :     Sodium Chloride (Nacl)18 
 
VERNACULAR NAMES : 
English                 :       Common salt, Table salt,  Muriate of sodium, 
                                     Muriate of soda 
Tamil                    :       Uppu 
Sans                  :       Lavana, Samudra-Lavana, Dronilavana 
Hind       :       Namak, Lun Nun. 
 
 
DISTRIBUTION     :        Common salt is widely distributed throughout the world. 
 
PROPERTIES OF SODIUM CHLORIDE : 
 
PHYSICAL PROPERTIES :19 
• Colourless crystals (or ) powder. 
• Odourless 
• Transparent cubical shaped white (or) brownish crystals. The colours such as red (or) 
blue (or) pale pink are also common. 
• These colours are eliminated on refining 
• Transparent to light and also in infrared region 
• Saline taste 
• Neutral Reaction 
• Melting point  801˚c 
• Boiling point 1465˚c (1738 k) 
• Molar mass 58.44277 gm /mol 
• Density 2.16 gm/ cm, solid. 
 
  
CHEMICAL PROPERTIES19 
 
It is readily soluble in water (i.e) 35.7 gm /100ml˚ of water  
 
35.9g/100ml (25˚c) 
39.8g /100 ml of waer at 100˚c 
 
• Slightly soluble in alcohol and insoluble in con.Hcl 
 
• PH of aqueous solution is 6.7- 7. 
 
• Salt decrepitates when heated and volatizes at white white 
       heat without decomposition 
 
• Other anions NaF, NaBr, NaI. Other cations Licl 
      Kcl,Rbcl,Cscl 
 
• Related salts sodium aceate. 
 
Sodium chloride is the salt most responsible for the salinity of the                                                                                               ocean and of the 
extra cellular organisms. As the major ingredient in edible salt. It is commonly used as a condiment and food preservative. In 1 gm of   Nacl 
,there are approximately 0.3933 gm of sodium and 0.6067 gms of chloride. 
 
BIOLOGICAL USES:19 
 
*      Many micro organisms can not live in an overly salty environment water is drawn out of 
their cells by osmosis. For this reason salt is used to preserve some foods, such as smoked bacon 
(or) fish and can also be used to detach leeches that have attached themselves to feed to disinfect 
wounds. 
* Salt would be rubbed in to household surfaces as a cleaning agent. 
 
 
BIOLOGICAL FUNCTIONS: 
*  In human, a high salt intake was demonstrated to attenuate nitrioxide                  
production. 
  
* Nitric oxide contributes to vessel homeostasis by inhibiting vascular                   
smooth muscle contraction and growth . platelet aggregation ,and leukocyte adhesion to the 
endothelium. 
 
MEDICINAL USES: 
1. The serum human blood contains 0.35% of weight of Nacl .It 
    maintains osmatic tension of the blood and the tissue fluids. 
 
2.Use of weak salt  solution helps in the prevention of heat cramps, giddiness due to heat              
   exhaustion ,vomiting and dehydration. 
 
3. Salt is of value  in the treatment of poisoing by bromides (or) 
     iodides , mercuric salt and phenol. 
 
4. Iodised salt is prescribed as a prophylactic of  goiter. 
 
5.Sodium chloride (SO E-dee-um KLOR –ide) as a20% solution is given  by  injection in to the      
    uterus to cause abortion. 
 
METHODS OF PRODUCTION OF SALT: 
The widely used methods of production are: 
1. Solar evaporation brines. 
2. Artificial evaporation of brines. 
3. Mining of rock salt. 
 
PURIFICATION OF SALT: 
Salt manufactured from  brines contains impurities such as sulphates of     sodium,calcium, magnesium and chlorides of potassium and 
magnesium.These impurities are eliminated by fractional crystallization  Or by treatment  with lime and soda ash. 
 
*Sodium sulphate is removed by fractional crystallization. 
*Magnesium impurities in the brines are are precipitated as hydroxides and 
*Calcium salts are removed  as carbonates by lime and soda ash method. 
 
VARITIES OF SALTS: 
In India  Common salt is classified in to numerous varieties depending on the percentage of Nacl 
and physical characteristics. 
  
 
Kuppa, Reshta, Kurkutch, Baragara, kyar, vajni, Mapi, Panga and Pan are among the important 
varieties manufactured in different  parts of the country. Among these mapi and vajni are the 
inferior variety salts. 
Mapi and vajni are produced in tamil nadu, kerala, Andrapradesh, mysore, orissa and maharastra  
states. The grain of mapi salt are very small and imperfect and are frequently , intermixed with 
gypsum. This variety is inferior to vajni. 
 
CHEMICAL COMPOSITION OF  MAPI & VAJNI IN PERCENTAGE; 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPEC
IAL 
VARI
ETIE
S OF 
SALT 
 
CHEMICAL 
 
 
MAPI 
 
VAJNI 
 
 
* Sodium chloride 
 
* Calcium sulphate 
 
*Magnisumsulphate 
 
*Magnisumchloride 
 
* Insolubles 
 
 
 
 
 
90.85 
 
1.43 
 
2.05 
 
3.82 
 
1.08 
 
 
 
 
 
 
92.93 
 
1.10 
 
1.85 
 
3.39 
 
1.01 
 
  
1.TABLE SALT: 
It is high purity, white ,crystalline salt possessing uniform grains and free flowing properties. It 
is prepared mainly for table use. 
 
2. DAIRY SALT.    : 
Common  salt required for the preservation of butter and cheese  should be  highly pure 
 (Nacl 99.7%) .Free from bacterial contaminations as well as calcium and magnesium 
impurities. 
 
3.. MEDICINAL SALTS: 
          *   Iodized salt 
          *   Iodized cattle –licks and sodium chloride B.P & I.P grades 
               are the varieties used for medicinal purposes 
 
QUALITY CONTROL AND STANDARDS: 
Quality of salt is judged by sodium chloride contents, impurities, present and particle size. The 
quality of salt manufactured in the country is to a large extent substandard, and also quality  
differs from region to region. To improve the quality of salt, the government of India imposed 
quality control measures in 1951, and the salt samples were sysmatically tested in the testing 
laboratories located in the producing center 
 
           Presently, except for the salt exported to japan there is no restriction on the quality of salt 
manufactured . 
 
 
 
 
 
In standard specifications for salt intended for various purposes are summarized 
below: 
  
 
 
TYPES 
 
 
 
Nacl CONTENT 
(min % by wt) 
 
 
PERMISSIBLELIMITS 
OFIMPURITIES(max% by wt) 
 
 
Edible salt 
 
 
    96 
 
 
 
Soluble impurities other than 
Nacl, 3.0; insoluble 1:0 
 
 
 
Table salt 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
 
 
Matter insoluble in water 2.2; 
Matter insoluble in acids 
1.48;Calcium (water soluble) 
0.05; 
Magnesium(water 
soluble)0.10 
Carbonate (water soluble) 
0.20 Lead 2.5 ppm; iron 50 ppm. Arsenic 
1 ppm 
 
 
Drugs and 
Pharmaceuticals 
 
 
 
 
 
 
 
99.5 
 
 
 
 
Heavy metals, 5 ppm; 
Arsenic 10 ppm;Iron , bromine, iodine, 
barium, 
Calcium, magnesium& 
Sulphates to pass  according To I.P tests. 
 
 
 
 
 
MATERIALS AND METHODS 
 
COLLECTION OF DRUG: 
  
Kariuppu  was bought from the raw drug market and was identified by   a   Chemist and 
the leaves of aegle marmelos were collected from the surroundings of Chennai and identified by 
botanist of National institute of siddha, Chennai- 47. 
PURIFICATION OF KARIUPPU: 
One volume of kariuppu was diluted in seven volume of water and is boiled down to a thick consistency (kuzhambu pakkuvam). Then 
added lemon juice to the warm stage of semi solid form. Then  content was kept for drying under sun light till the water in karippu evaporates 
completely ,  For complete purification repeated the procedure for 10 times. Then The purified kariuppu was kept in an air tight container. 
PREPARATION OF MEDICINE: 
The purified salt was taken in a pot (red clay) and added juice of  vilva  leaves (Aegle marmelos) up to four inches above the salt  
level. Soaked the salt for two days. On the third day, covered the pot (red  clay) with mud plate and closed it with cloth  dipped in the mud paste. 
Allowed it to dry. Put pudam with seven parts of varatti according to weight of the pot. Then take the durg  after  it cooled  down.. Then grinded 
by stone mortor and pestle in to fine powder form. The kariuppu parpam was taken and weighed  and kept in a covered porcelin vessel . 
ADMINISTRATION OF DRUG : 
Route  of administration :   Enteral  , 500 mg  twice daily after diet with Honey 
Duration                        :    24 days (1/2 mandalam). 
METHODOLOGY 
*Physicalproperties  
*  Bio- chemical analysis 
*  Acute toxicity study 
*  Anti- ulcer activity. 
*  Clinical study 
Were done on kaiuppu parpam and methods of study  are given as follows and the observation and results of the analysis are given in the 
appropriate headings. 
BIO-CHEMICAL ANALYSIS 
 
PHYSICAL PROPERTIES 
The standardization parameters of kariuppu parpam was done at mettex laboratories of India, 
Guindy, Chennai-32.  
 
The tests done are as follows: 
1.  Loss of drying @ 105˚c : 
  
Five grams of kariuppu parpam is heated in a hot oven at 105˚ c to constant weight. The 
percentage of loss of weight was calculated. 
 
2. Determination of ash value: 
Weigh accurately 2-3 grams of kariuppu parpam intarred platinum (or) silica dish and incinerate 
at a temperature not exceeding 450˚c until free from carbon, cool and weigh. Calculate the 
percentage of ash with reference to the air dried drug . 
 
3. Water  soluble ash: 
To the Gooch crucible containing to the total ash, add 25 ml of water and boil for 5 minites. Collect the insoluble matter in a sintered glass 
crucible or on ash less filter paper.wash with hot water and ignite in a crucible for 15 mintes at a temperature not exceeding 450˚c  substract the 
weight of the insoluble matter from the weight of the ash the difference of the weight represents the water soluble ash. Calculate the percentage of 
water soluble ash with reference to the air dried drug. 
 
4.  Alkalinity as Caco3 in water soluble ash: 
Five grams of kariuppu parpam converted to ash, boiled with water filtered. Fitrated was tiltrated 
against 0.1 N  of Hcl using phenophthaelin as an indicator. 
Alkalinity of water soluble ash =   X x  of acid / 0.1  x  W 
 
 
X   -  Titre value 
W   -  weight of the material taken. 
Alkalinity is given as ml of 0.1 N  of Hcl  equated to 1 gm. 
 
5.  Acid insoluble ash: 
Boil the ash for  5 minutes with 25 ml of 1 : 1  dilute Hcl. Collect the insoluble matter in Gooch- crucible on an ash less filter parper wash with 
hot water and ignite. Cool in a dessicator and weigh. Calculate the percentage of acid insoluble ash with reference to the air dried drug. 
 
6.  PH at 10 % aqueous solution : 
Five grams of Kariuppu parpam is weighted accurately and placed in clear 100 ml  beaker. Then 
50 ml of distilled water is added to it and dissolved well. Wait for 30 minutes and then apply in 
to PH mater at standard buffer solution of 4.0, 7.0, and 9.2. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 gms of Kariuppu parpam is weighted accurately and placed in clear 100ml beaker.  Then 50ml 
of distilled water is added to it and dissolved well.  Wait for 30 minutes and then apply in pH 
meter at standard buffer solution of 4.0, 7.0 and 9.2. 
 
 
Sl. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample  Ash in colour  
2. Solubility: 
a.  A little of the sample is shaken 
well with distilled water 
b.  A little of the sample is shaken 
well with con Hcl / con H2So4 
 
Sparingly soluble 
 
Completely soluble 
 
 
 
Absence of silicate 
3. Action Of Heat:   
  
A small amount of the sample is 
taken in a dry test tube and heated 
gently at first and then strongly 
White fumes evolved 
 
No brown fumes 
Presence of Carbonate 
 
Absence of Nitrate 
4. Flame Test: 
A small amount of the sample is 
made in to a paste with con. Hcl in 
a watch glass and introduced into 
non-luminous part of the Bunsen 
flame 
 
No bluish green 
flame appeared 
 
Absence of Calcium 
5. Ash Test: 
A filter paper is soaked into a 
mixture of sample and add cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited 
 
Yellow Colour flame 
present 
 
Presence of sodium 
 
 
PREPARATION OF EXTRACT: 
5 gm of Kariuppu parpam is weighed accurately and placed in a 250 ml clean beaker and 
added with 50ml of distilled water. Then it is boiled well for about 10 minutes.  Then it is cooled 
and filtered in a 100ml volumetric flask and made up to 100ml with distilled water. 
 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
I Test For Acid Radicals   
1.  
Test For Sulphate: 
c. 2 ml of the above prepared 
extract is taken in a test tube, to 
this, add 2ml of 4% ammonium 
oxalate solution 
d. 2 ml of the above prepared 
 
 
Cloudy appearance  
Present 
 
 
 
 
 
Presence of sulphate. 
 
 
 
 
  
extract is added with 2ml of dil, 
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution 
is added 
A white precipitate 
insoluble in con. Hcl 
is obtained 
Sulphate is confirmed. 
2. Test For Chloride: 
2 ml of the above prepared extract is 
added with dil. HNo3 till the 
effervescence ceases.   Then 2ml of 
silver nitrate solution is added 
 
cloudy appearance 
Present 
 
Presence of chloride 
3. Test For Phosphate: 
2 ml of the extract is treated with 2ml of 
ammonium molybdate solution and 2ml 
of Con. HNO3 
 
cloudy yellow 
appearance 
 
Presence of phosphate 
4. Test For Carbonate: 
2 ml of the extract is treated with 2ml of 
magnesium sulphate solution 
 
No Cloudy 
appearance 
 
Absence of Carbonate 
5. Test For Nitrite: 
1 gm of the substance is heated with 
copper turning and concentrated H2So4 
and viewed the test tube vertically down 
 
No characteristic 
changes 
 
Absence of Nitrate 
6. Test For Sulphide: 
1 gm of the substance is treated with 2 
ml of Con. Hcl 
 
No Rotten egg 
smelling gas evolved 
 
Absence of sulphide` 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil 
acetic acid and 2ml of calcium chloride 
solution and heated 
 
No cloudy 
appearance 
 
Absence of fluoride and 
oxalate 
8. Test For Nitrite: 
3 drops of the extract is placed on a 
 
No Characteristic 
 
Absence of Nitrite 
  
filter paper, on that 2 drops of acetic 
acid and 2 drops of benzidine solution is 
placed. 
changes 
9. Test For Borate: 
2 pinches of the substance is made into 
paste by using sulphuric acid and alcohol 
(95%) and  introduced into the blue flame 
 
 
Bluish green colour 
flame not appeared 
 
Absence of Borate 
 
1. 
Test For Basic Radicals 
Test For Lead 
2 ml of the extract is added with 2ml of 
potassium iodide solution 
 
No yellow precipitate 
 
Absence of lead 
2. Test For Copper 
c. One pinch of substance is made in to 
paste with con. Hcl in a watch glass 
and introduced into the non – 
luminous part of the bunsen flame. 
 
d. 2 ml of extract is added with excess of 
ammonia solution 
 
Blue colour  flame 
 
 
 
 
Blue colour 
precipitate formed 
 
Presence of copper 
 
 
 
 
Presence of copper 
3. Test For Aluminium: 
To the 2ml of the extract sodium hydroxide is 
added in drops to excess 
 
No characteristic 
changes 
 
Absence of aluminium 
4. Test For Iron. 
c. To the 2ml of extract add 2 ml of 
ammonium thiocyanate solution. 
d. To the 2ml of extract add 2ml 
ammonium thiocynate solution and 
2ml of con HNo3 is added 
 
 
No mild red colour 
appeared 
No Blood red colour 
appeared 
 
Absence of Iron 
 
Absence of Iron 
5. Test For Zinc white precipitate is Presence of Zinc 
  
To 2ml of the extract sodium hydroxide 
solution is added in drops to excess 
formed  
6. Test For Calcium 
2ml of the extract is added with 2ml of 4% 
ammonium oxalate solution 
 
Cloudy appearance 
white precipitate is 
obtained 
 
Presence of Calcium 
7. Test For Magnesium 
To 2ml of extract sodium hydroxide solution 
is added in drops to excess 
 
White Precipitate is 
obtained 
 
Presence of 
Magnesium 
8 Test For Ammonium: 
To 2ml of extract few ml of Nessler’s reagent 
and excess of sodium hydroxide solution are 
added 
 
No Brown colour 
appeared 
 
Absence of ammonium 
9. Test For Potassium:A pinch of substance is 
treated with 2ml of sodium nitrate solution 
and then treated with 2ml of cobalt nitrate in 
30% glacial acetic acid 
No Yellowish 
precipitate is obtained 
Absence of Potassium 
10. Test For Sodium 
2 Pinches of the substance is made into paste 
by using Hcl and introduced in to the blue 
flame, of Bunsen burner 
 
Yellow colour flame  
appeared 
 
Presence of Sodium 
11. Test For Mercury 
2 ml of the extract is treated with 2ml of 
sodium hydroxide solution 
 
No yellow precipitate 
is obtained 
 
Absence of Mercury 
12. Test For Arsenic: 
2ml of extract is treated with 2ml of silver 
nitrate solution 
 
No brownish red 
precipitate is obtained 
 
Absence of Arsenic 
III. Miscellaneous:   
1. Test For Starch: 
2 ml of extract is treated with weak Iodine 
solution 
 
No blue colour 
developed 
 
Absence of starch 
  
2. Test For Reducing Sugar: 
5 ml of Benedicts qualitative solution is taken 
in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
changes are noted 
 
Brick red colour 
developed 
 
Presence of Reducing 
sugar 
3. Test For The Alkaloids: 
c. 2ml of the extract is treated with 2ml 
of potassium iodide solution. 
d. 2ml of extract is treated with 2ml of 
picric acid. 
e. 2ml of the extract is treated with 2ml 
of phosphotungstic acid 
 
 
No red colour 
developed 
 
Yellow colour 
developed 
No White precipitate 
obtained 
 
 
 
 
Presence of alkaloid 
 
4. Test For Tannic Acid: 
2 ml of extract is treated with 2ml of ferric 
chloride solution 
 
No Black precipitate 
appeared 
 
Presence of Tannic acid 
 
5. Test For Unsaturated 
Compound: 
To the 2ml of extract 2ml of potassium 
permanganate solution is added 
 
 
Potassium 
Permanganate is not 
decolourised 
 
 
Absence of unsaturated 
compound 
6. Test For Amino Acid: 
2 drops of the extract is placed on filter paper 
and dried well 
 
No Violet colour 
developed 
 
Absence of amino acids
7. Test for Type of Compound 
2 ml of the extract is treated with 2 ml of 
ferric chloride solution 
 
No green colour 
developed 
 
No Red colour 
developed 
 
Absence of oxy quinole 
epineplhrine and phro 
catechol 
Anti pyrine, Aliphatic 
amino acids and 
  
 
No violet colour 
developed 
 
No Blue colour 
developed 
meconic acid are absent
Apomorphine salicylate 
and resorcinol are 
absent 
 
Morphine, phenol 
cresol and hydro 
quinine are absent 
 
 
 
 
 
 
 
 
ACUTE TOXICITY STUDY OF KARIUPPU PARPAM 
 
Kariuppu parpam suspended in 2% CMC was administered to the groups of wistar rats 
in a single oral dose by gavage using a feeding needle. The limit test dose of 4000mg/kg was 
used. All the animals were sequentially dosed at interval of 1hour were used for the short term 
observation test. The control group received an equal volume of the vehicle. Observations were 
made and recorded systematically 1, 2, 4 and 24 hrs after substance administration. The visual 
observations included skin changes, morbidity, aggressiveness, sensitivity to sound and pain, as 
well as respiratory movements and mortality. They were deprived of food, but not water 16–18 h 
prior to the administration of the test suspension. Finally, the number of survivors was noted 
after 24 h and these animals were then maintained for a further 13 days (long term observation 
  
period) and observations made daily. The toxicological effect was assessed on the basis of 
mortality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STUDY ON ANTIULCER EFFECT OF KARIUPPU PARPAM IN PYLORUS LIGATED 
ALBINO RATS 
ANIMALS 
Wistar albino rats of either sex weighing 200-250 g were selected. Rats were fed with 
standard pellet diet and water ad libitum till the end of the experimental period.  Distributions of 
animals in a group, sequence of trials and to treatment aspects were randomized. 
 
DRUG SOLUTION 
 
Drug was suspended 2% CMC in distilled water were administered orally to rats in dose 
of 400 mg/kg. Saline treated (0.5 ml/100 g, p.o.) rats served as control. The dose of Kariuppu 
parpam was selected on the basis of single large dose acute toxicity study values in mice. 
  
 
PYLORUS LIGATION INDUCED ULCERATION 
Rats were fasted for 12 hrs, care being taken to avoid coprophagy. Under light-ether 
anaesthesia pylorus ligation was carried out. After 4 h of pylorus ligation rats were killed with 
high dose of anaesthetic ether. The stomach was then taken out and cut open along the greater 
curvature and ulcer index was determined. Gastric juice was subjected to biochemical analysis. 
Total acid output (TAO), total carbohydrates (TC) and protein content (PR) were estimated. 
Drug was administered 30 min prior to pylorus ligation. 
 
STATISTICAL ANALYSIS OF RESULTS: 
 
The results were expressed as mean+SEM and were analyzed for statistically significant 
difference using one-way ANOVA followed by Dunnett’s multiple comparison test. P values 
<0.05 were considered significant. 
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GUNMAM  IN  MODERN  ASPECT 
PEPTIC ULCER20 
DEFINITION : 
      Peptic ulcer refers  to an ulcer in the lower oesophagus, stomach   (or)  duodenum (upper GI  
tract). 
 
ETIOPATHOGENESIS: 
 
 Hereditary   factors - 
 Strong familial history with gastric ulcer. 
 Less familial history with duodenal ulcer 
  
 Concept of  peptic ulceration is acid & pepsin Vs  mucosal resistance factor. If there is an 
imbalance between this acid pepsin& mucosal resistance patterns is results in peptic 
ulcer. 
 Severe ulceration occurs in Zollinger – Ellison syndrome which is characterstic by high 
acid secrection is more important in the etiology of duodenal ulcer than gastric ulcer. 
 
 Factors reducing mucosal resistance : 
 Drugs like NSAIDS  used in rheumatoid  arthritis 
 Aspirin 
 Smoking & Alcohol 
 Organism. Helicobacter pylori. 
 
 HELIOBACTER PYLORI: 
H.pylori is a gram negative bacillus produces mucosal damage . In developed country  
H.pylori is present in 80% people by 20 yrs ag 
   
TRANSMISSION: 
Muco- oral  route . 
It is an organism, which produces urease . It causes  gastritis. 
 
 
CLINICAL FEATURES: 
 
           Signs &  Symptoms : 
Most common  presentation is recurrent abdominal 
pain.  The abdominal pain has three notable  characters : 
1..Localisation of the pain –Epigastric region 
2..Relationship to food 
3.Periodicity 
 
¾ Epigastric pain : 
  
            Patient will have epigastric pain sharply localized. Patient will  able to locate the site of 
the pain with one finger. 
It is called  “ Pointing  sign ˝.  Pain is burning in nature 
               Hunger pain : 
Pain occurs on empty  stomach is called hunger pain . which is    relieved by food (or) antacids. 
                Night pain : 
Typically the pain wakes the patient from sleep around  3 a.m . Relieved by food, milk,(or) 
antacid. 
 
¾ Relationship to food : 
         Pain is relieved by food , milk (or) antacids. 
 
¾ Periodicity : 
[Episodic pain ] 
Pain occurs in episodes lasting one to three weeks every time     (3 to 4 times a year) 
between the episoides patient will be normal. 
 
 
 
 
 
 
DIFFERENCE  BETWEEN  GASTRIC &  DUODENAL ULCER 
 
 
 
 
GASTRIC ULCER 
 
DUODENAL ULCER 
  
 
Age 
sex 
[Course of 
Illness] 
Episodes of pain 
Antacids 
 
Food 
Heart burn 
Night pain 
Haematamisis 
Malaena 
 
More than 40 yrs 
Equal 
 
Less remittent 
Long duration 
Relief of pain  nonconstant 
 
Provokes pain 
Less common 
Less common 
More 
Less 
 
20  -  50  yr 
More male 
 
More remittent 
Short duration 
Relief of pain will be 
prompt 
Relieves pain 
More common 
more common 
Less 
More 
 
 
 
 
 
 
 
INVESTIGATIONS: 
 
 Double  contrast barium meal series 
 Show ulcer as duodenal ulcer- Deformed duodenal cap 
 Upper GI endoscopy  - Can visualise ulcer & Take biopsy to role out malignancy. 
10% gastric ulcer are malignant. 
  
 
OTHER INVESTICATIONS: 
 
Test for pylori  Serum gastric acid analysis in patient with Zollinger –Ellison 
syndrome. 
 Endoscopy & Biopsy of H.Pylori sent sample for histology for Giemsa staining. 
 Rapid urease test. 
 
COMPLICATIONS: 
 
 Upper GI bleeding 
 Perforation 
 Gastric outlet obstraction 
                        Malignancy  (With gastric ulcer only ).  
 
 
 
 
 
 
 
 
 
 
 
CLINICAL  STUDY 
SELECTION OF PATIENTS: 
30 Patients  of both sexes were selected from the out patient 
Department of Nationl institute of siddha, Chennai-47. By present inclusion and exclusion 
criteria. 
CRITERIA FOR SELECTION: 
  
Inclusion criteria: 
1. Age 20- 60 years 
2. Epigastic pain, heart burn, nausea, vomiting, indigestion, confirmed by envagai thervu and 
endoscopy. 
3. Willing to be admitted in the hospital for 24 days (or) willing to attend OPD once in 8 days for 
24 days. 
Exclusion criteria: 
1. Complications of peptic ulcer, radiating abdominal pain (Pancreatitis, appendicitis, acute abdominal colic pain ). 
2. Malignancy 
3. Intestinal obstraction 
4. Gall stone, hiatus hernia, jaundice 
5.  Hypertension 
 
WITHDRAWAL CRITERIA 
Increase in epigastric pain, incidence of diarrhea other acute illness during trial  period 
LINE OF TREATMENT: 
The drug kariuppu parpam was administrated internally in dose of 
500 mg two times a day with honey after diet. 
DIET RESTRICTION: 
Patient were advised to avoid : 
1. Spicy food, tubers and cereals 
2. Smoking 
3. Alcohol 
4.To follow diet at regular intervals. 
RESULTS OF BIOCHEMICAL ANALYSIS 
 
The given sample contains 
 
• Copper 
• Sulphate 
• Zinc 
• Sodium 
  
• Calcium 
• Chloride 
• Magnesium 
• Tannic Acid 
• Phosphate 
• Reducing sugar 
• Alkaloid 
 
RESULTS OF STANDARDISATION PARAMETERS : 
 
1. Loss on drying    4.52 
2. Total Ash value    79.12 
3. Water soluble Ash    92.7 
4. Alkalinity as CaCo3  in water soluble Ash     0.25 
5. Acid insoluble Ash    0.58 
6. PH at 10% aqueous solution     9.70 
 
 
 
 
 
 
ACUTE TOXICITY STUDY OF KARIUPPU PARPAM 
 
Results 
 
 
  
The limit dose of 4mg/kg did not cause any mortality or any signs of toxicity in any of the 
animal used in this study. The animals did not show any changes in behavior or other 
physiological activities. But the symptoms like continuous grooming, in the entire group and 
increase in respiration rate was generally observed in the animals (Table-1). No death was 
recorded during the treatment period in either the control or treated groups given upto the 
maximum of 4g/kg of Kariuppu parpam orally. No pathological alterations were grossly 
detected in vital organs after sacrificing. The organs of both control and treated groups were 
unremarkable and comparable to each sex. Pathological examinations of the tissues on a gross 
and macroscopic basis indicated that there were no detectable abnormalities. it can be concluded 
that a test substance is practically non-toxic or non-lethal after an acute exposure. This test limit 
for acute oral toxicity is generally considered to be 4.0g/kg body weight. If no mortality is 
observed at this dose level, a higher dosage is generally not necessary as per the standard 
guidelines. 
 
 
 
 
 
 
 
 
 
 
 
Incremental dose finding experiment and its Signs of Toxicity 
 
  
 
No Treatment 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 I 50 + - - + + + - - - - - - - - - - - - - - 
2 II 100 + - - + + + - - - - - - - - - - - - - - 
3 III 250 + - - + + + - - - - - - - - - - - - + - 
4 IV 500 + - - + + + - - - - - - - - - - - - + - 
5 V 1000 + - - + + + - - - - - - - - - - - - + - 
6 VI 2000 + - - + + + - - - - - - - - - - - - + - 
7 VII 4000 + - - + + + - - - - - - - - - - - - + - 
 
 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Increased Motor Activity 8. Tremors 9. 
Convulsions 10. Muscle Spasm 11. Catatonia 12. Musclerelaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 
18. Writhing 19. Respiration 20. Number of Deaths (Mortality) 
 
 
 
 
 
 
 
STUDY ON ANTIULCER EFFECT OF KARIUPPU PARPAM IN  
PYLORUS LIGATED ALBINO RATS 
RESULTS 
 
In pylorus ligated rats Kariuppu parpam showed significant reduction in ulcer index when 
compared with control group. Among the acid secretory parameters reduction in TAO was also 
significant at the dose of 400mg/kg whereas effect on pepsin activity was insignificant. 
  
Treatment with drug produced insignificant alteration in TC of gastric juice. However, a 
significant decrease in PR of gastric juice was observed (Table 1). These results suggest that 
besides reduction in total acid output and enhancement of mucin activity other mechanisms may 
also play a role in gastroprotection afforded by Kariuppu parpam. The results of the present 
study confirm the antiulcer activity of Kariuppu parpam against gastric ulceration in rats. The 
mechanism for antiulcer action of Kariuppu parpam may be attributed partially to decrease in 
acid secretion and enhancement of mucin activity. However, more investigations need to be done 
to elucidate the exact mechanism of antiulcer activity of Kariuppu parpam. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1—Effect of Kariuppu parpam on total and free acidity, gastric volume and ulcer index 
[Values are mean ± SE from 6 animals in each group] 
 
  
Groups Total acidity 
(mEq/l) 
Free aciditly 
(mEq/l) 
Gastric Volume 
(ml/100g) 
Ulcer index 
CMC Normal control 
 
ligation control 
 
Ranitidine (50mg/kg) 
 
KUP(400mg/kg) 
171.12±1.84* 
 
236.18±3.01 
 
187.22±1.40* 
 
203.65±1.33* 
132.1±2.14* 
 
189.5±2.41 
 
148.76±2.20* 
 
144±1.47* 
2.74±0.01* 
 
5.19±0.05 
 
3.41±0.02* 
 
3.56±0.03* 
1.25±0.03* 
 
4.28±0.04 
 
1.88±0.04* 
 
2.57±0.02* 
*P values <0.001 as compared to ligation control 
 
 
Table 2—Effect of Kariuppu parpam on mucin activity of gastric juice in pylorus ligation 
induced ulcers [Values are mean ± SE from 6 animals in each group] 
 
 
 
 
 
 
 
 
 
 
 
*P values <0.001 as 
compared to ligation 
Groups Protein 
(mg/ml) 
TC (mg/ml) 
 
Ligation control 
 
Ranitidine (50mg/kg) 
 
KUP (400mg/kg) 
 
 
266.07±5.01 
 
314.52±2.58* 
 
291.16±4.11* 
 
 
1648.14±23.08 
 
1591.54±18.03* 
 
1356.32±24.43* 
 
  
control 
 
0
50
100
150
200
250
CMC Normal Control Ligation Control Ranitidine (50 mg / kg) KUP (400 mg / kg)
ANTI ULCER 
Total Acidity  (mEq/1) Free aciditly (mEq/1) Gastric Volume (ml/100 g) Ulcer Index
 
 
 
  
ligation control
Ranitidine (50mg /
kg) KUP (400 mg / kg)
PROTEIN (mg / ml)
TC (mg / ml)
0
200
400
600
800
1000
1200
1400
1600
1800
EFFECT OF KARIUPPU PARPAM
 
RESULTS OF CLINICAL ASSESSMENT 
Table -3   AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
AGE 
 
PERCENTAGE 
 
1. 
 
20-30 years 
 
30% 
  
0
5
10
15
20
25
30
35
40
20-30 yrs 30-40 yrs 40-50 yrs 50-60 yrs
AGE DISTRIBUTION
NO OF PATIENTS IN PERCENTAGE
 
 
For the clinical study of kariuppu parpam in gunmam. 30 patients were selected. 
According to age wise distribution 30% were in 20-30 yrs, 40% were in 30-40 yrs, 13.33% were 
in 40-50 yrs, 16.67% were in 50-60 yrs. 
 
 
Table  no: 4     SEX DISTRIBUTION 
 
S.No 
 
SEX PERCENTAGE 
 
1. 
 
Female 
 
43.33% 
 
 
2. 
 
Male 
 
56.67% 
 
 
 
 
2. 
 
30-40 years 
 
40% 
 
3. 
 
40-50 years 
 
13.33% 
 
4. 
 
50-60 years 
 
16.67% 
  
13
17
43.33
56.67
0
10
20
30
40
50
60
NO.OF PATIENTS IN PERCENTAGE
SEX DISTRIBUTION 
Female Male
 
 
According to sex wise distribution 43.33% were in female , 56.67% were in male. 
 
 
 
RESULTS OF STATISTICAL ANALYSIS 
Improvement showing signs and symptoms before and after treatment 
 
SNO 
 
 
 
Symptoms 
 
Number of pt 
Before 
Treatment 
 
 
Number of pt 
After 
Treatment 
 
 
Percentage 
1. Epigastric Pain 30 1 96.67% 
2. Heart Burn 23 1 95.65% 
3. Nausea 11 1 90.90% 
4. Vomiting 6 0 100% 
5. Indigestion 19 1 94.47% 
6. Loss of Appetite 8 0 100% 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
30
1
23
1
11
1
6
0
19
1
8
0
18
1
0
5
10
15
20
25
30
EP HB NA VO IN LA AD
SIGNS AND SYMPTOMS
BEFORE TREATMENT AFTER TREATMENT
 
From  the clinical study 96.67% of patients get relieved from epigastric pain, 95.65% get 
relieved from  Heart burn, 90.90% patients get relieved from nausea, 100% patients get relieved 
from vomiting, 94.74% patients get relieved from indigestion , 100% patients get relieved from 
loss of appetite, 94.44% get relieved from abdominal discomfort and no adverse effects were 
observed.From the cliical and stastical analysis, it is proved  that the drug kariuppu parpam is 
staistically  significant. 
7. Abdominal Discomfort 18 1 94.44% 
  
 
GUNMAM (PEPTIC ULCER) - BLOOD  INVESTIGATION – BEFORE TREATMENT 
 
 
 
 
S.No 
 
OP/IP No 
 
   Hb  
  gm% 
 
       TC 
     Cells/ 
         
                      DC 
    
  ESR 
 
Blood 
Sugar 
 
 
Urea 
 
 
Crea 
 
 
CHO 
           
                URINE 
             Deposit 
  
                                                           
     cu.mm P% L% E% M% ½ hr 
mm 
1hr 
mm 
 (R) 
mg/dl 
Mg% Mg% 
 
Mg% Alb Sug Pus 
Cells 
Epi 
Cells 
1 AG2220 13.5 8150 60 35 4 1 9 12 104 28 0.6 180 Nil Nil 6-8 1-2 
2 A2938 12.6 6800 52 40 2 - 14 30 84 27 0.8 135 Nil Nil 3-5 1-2 
3 742 10.6 8000 50 43 5 - 24 48 128 23 0.7 176 Nil Nil 6-8 1-6 
4 AG1539 8.7 4500 50 48 2 - 5 10 95 24 0.8 195 Nil Nil 1-2 2-3 
5 AF8247 15.6 6000 50 47 2 - 3 3 123 17 0.7 184 Nil Nil 1-2 1-2 
6 AG3930 12.5 7800 54 42 3 1 9 18 96 18 0.5 197 Nil Nil 2-4 4-6 
7 AG1910 15 9800 60 35 5 - 10 22 160 21 0.6 160 Nil Nil 2-4 2-4 
8 AG4064 13.1 8800 60 38 2 - 5 10 61 23 0.5 159 Nil Nil 2-3 1-2 
9 AG4225 13.5 6000 53 45 2 - 2 5 94 17 0.6 190 Nil Nil 1-2 2-3 
10 AG4262 16 6100 50 47 3   - 10 20 88 22 0.8 170 Nil Nil 2-4 2-4 
11 AG6445 13.1 7900 50 45 5 - 2 4 60 13 0.6 160 Nil Nil 1-2 1-2 
12 AG4306 12.2 8200 52 46 2 - 4 10 86 21 0.7 158 Nil Nil 1-2 1-2 
13 AG6441 12.6 7900 54 40 4 - 4 8 74 13 0.8 178 Nil Nil 1-2 1-2 
14 N9335 11 5600 50 48 2 - 6 15 99 18 0.5 175 Nil Nil 3-4 1-2 
15 AG8625 13.1 6200 52 47 1 - 3 6 70 18 0.7 113 Nil Nil 2-3 2-3 
16 AG4055 12 8400 54 42 3 - 4 8 100 32 0.7 178 Nil Nil 1-3 1-2 
17 AG9408 10.6 6800 55 42 3 - 1 8 118 18 0.6 172 Nil Nil 2-3 1-2 
18 AG7238 15.2 7500 56 42 2 - 11 34 91 26 0.8 169 Nil Nil 2-3 1-2 
19 AG2611 13 6900 53 40 6 1 15 33 64 28 0.7 136 Nil Nil 6-8 1-2 
20 755 10.7 5500 50 42 3 - 6 12 128 24 0.7 185 Nil Nil 1-2 2-3 
21 AH172 14 8500 59 38 3 - 6 12 109 21 0.6 187 Nil Nil 2-4 1-2 
22 AH459 12.6 6900 56 40 4 - 10 12 110 26 0.8 183 Nil Nil 2-4 2-4 
23 AH1717 12.1 4900 53 43 4 - 4 8 92 20 0.7 146 Nil Nil 2-3 1-2 
24 AH1424 9 8900 54 41 3 2 12 24 72 25 0.9 178 Nil Nil 1-2 1-2 
25 AH3803 12.6 6800 56 38 4 2 4 8 120 17 0.6 190 Nil Nil 3-4 2-3 
26 AG9003 15.5 8800 54 42 2 2 3 6 102 17 0.7 118 Nil Nil 2-3 2-4 
27 AI8835 13.5 7900 54 41 5 - 12 24 86 21 0.7 176 Nil Nil 2-4 4-6 
28 AG5213 12.1 6200 55 42 3 - 5 10 125 18 0.6 167 Nil Nil 3-4 2-3 
29 AG3487 13.1 9600 50 41 7 - 5 11 119 30 0.5 180 Nil Nil 1-2 0-1 
30 875 12.5 7600 57 37 6 - 19 38 117 34 0.7 170 Nil Nil 2-3 2-4 

  
                                                                     
                                                                
 
GUNAM (PEPTIC ULCER) - BLOOD  INVESTIGATION – AFTER TREATMENT 
 
S.No 
 
OP/IP No 
 
   Hb  
  gm% 
 
 
       TC 
     Cells/ 
    cu.mm 
         
                      DC 
    
  ESR 
 
Blood 
Sugar 
 (R) 
mg/dl 
 
 
Urea 
Mg% 
 
 
Crea 
Mg% 
 
 
 
CHO 
Mg% 
           
                URINE 
 
P% 
 
L% 
 
E% 
 
M% 
 
½ hr 
mm 
 
1hr 
mm 
 
Alb 
 
Sug 
     Deposit 
Pus 
Cells 
Epi 
Cells 
1 AG2220 13.6 7200 56 42 02 - 5 11 89 24 0.6 180 Nil Nil 1-2 2-3 
2 A2938 10.6 6800 52 45 03 - 12 18 98 21 0.8 135 Nil Nil 1-2 1-2 
3 742 11 8000 50 43 05 - 14 24 118 25 0.7 176 Nil Nil 1-2 1-2 
4 AG1539 10.3 7900 62 34 04 - 20 25 96 30 0.8 195 Nil Nil 2-4 2-4 
5 AF8247 13.5 6100 53 42 05 - 13 23 88 15 0.7 184 Nil Nil 1-3 1-3 
6 AG3930 11.7 7200 56 38 04 02 9 20 93 16 0.5 197 Nil Nil 1-2 1-2 
7 AG1910 12.5 7100 57 36 07 - 13 21 94 18 0.6 160 Nil Nil 1-3 1-2 
8 AG4064 13.4 6300 56 38 04 02 2 4 86 17 0.5 159 Nil Nil 1-2 2-5 
9 AG4225 13.5 8000 54 42 04 - 4 8 99 16 0.6 190 Nil Nil 2-4 2-4 
10 AG4262 15.5 7800 50 45 03   02 22 44 122 11 0.8 170 Nil Nil 1-2 1-2 
11 AG6445 11 6800 53 45 02 - 14 24 100 20 0.6 160 Nil Nil 1-2 2-4 
12 AG4306 10.5 7300 51 42 07 - 13 22 113 18 0.7 158 Nil Nil 1-3 2-3 
13 AG6441 12.9 8000 58 42 02 - 13 28 110 17 0.8 178 Nil Nil 2-3 2-4 
14 N9335 12.2 7300 56 38 04 02 10 20 107 30 0.5 175 Nil Nil 1-2 1-2 
15 AG8625 14.5 6800 58 38 04 - 2 4 76 23 0.7 113 Nil Nil 1-4 1-2 
16 AG4055 15 6100 50 46 04 - 12 25 94 19 0.7 178 Nil Nil 2-3 1-3 
17 AG9408 10 7000 51 46 03 - 11 23 100 16 0.6 172 Nil Nil 1-2 2-4 
18 AG7238 12.1 5900 52 42 05 01 12 21 97 17 0.8 169 Nil Nil 1-3 2-3 
19 AG2611 11.3 6300 57 40 03 - 7 14 102 15 0.7 136 Nil Nil 1-2 1-4 
20 755 10 6200 52 45 03 - 10 12 112 26 0.7 185 Nil Nil 2-3 2-3 
21 AH172 11.2 5800 50 45 05 - 8 16 101 19 0.6 187 Nil Nil 1-2 1-2 
22 AH459 10.8 7200 55 42 02 01 7 12 95 16 0.8 183 Nil Nil 2-4 2-3 
23 AH1717 12.3 6700 51 43 05 01 13 19 98 21 0.7 146 Nil Nil 2-5 2-3 
24 AH1424 14.1 7400 53 40 07 - 15 30 96 17 0.9 178 Nil Nil 2-4 1-4 
25 AH3803 13.5 6600 51 42 07 - 22 28 78 23 0.6 190 Nil Nil 1-3 2-3 
26 AG9003 9.8 6400 50 46 03 01 4 10 126 18 0.7 118 Nil Nil 1-2 1-2 
27 AI8835 13 7500 56 40 04 - 10 20 102 25 0.7 176 Nil Nil 2-4 3-4 
28 AG5213 12.6 7300 58 40 02 - 11 23 108 20 0.6 167 Nil Nil 1-3 2-3 
29 AG3487 11.8 6700 52 45 03 - 15 28 96 21 0.5 180 Nil Nil 1-4 1-2 
30 875 12.3 7100 51 44 05 - 6 15 98 16 0.7 170 Nil Nil 1-2 2-3 

  
 
 
GUNMAM (PEPTIC ULCER)  - IMPROVEMENT REPORT 
 
 
* Ep – Epigastric Pain   * Hb – Heart burn  * Na – Nausea  * Vo – Vomiting * In – Indigestion  * La – Loss of Appetite  * Ad – Abdominal Discomfort. 
 
 
 
S.No 
 
 
OP/IP No 
 
 
AGE 
 
 
SEX 
 
 
Ep 
BT 
 
 
Ep 
AT 
 
 
Hb 
BT 
 
 
Hb 
AT 
 
 
Na 
BT 
 
 
Na 
AT 
 
 
Vo 
BT 
 
 
Vo 
AT 
 
 
In 
BT 
 
 
In 
AT 
 
 
La 
BT 
 
 
La 
AT 
 
 
Ad 
BT 
 
 
Ad 
AT 
1 AG2220 30 M + - + - - - - - + - + - + - 
2 A2938 38 F +     - +     - -     -     -     - + - - - + - 
3 742 31 F +     - +     - +     -     -     - - - - - + - 
4 AG1539 38 F + - + - - - - - + - - - + - 
5 AF8247 38 M +     - +     - -     -     -     - + - - - + - 
6 AG3930 51 F +     - -     - +     -    +     - + - - - + - 
7 AG1910 39 M + - + - - - - - - - - - + - 
8 AG4064 28 M +     - +     - -     -     -     - + - - - - - 
9 AG4225 44 M +     - +     - +     -     -     - - - + - - - 
10 AG4262 39 M + - + - - - - - - - - - + - 
11 AG6445 35 M +     - -     - +     -     +     - + - + - - - 
12 AG4306 40 F +     - +     - +     -    +     - + - + - - - 
13 AG6441 40 M + - - - + - - - + - - - + - 
14 N9335 60 M +     - +     - -     -     -     - + - - - + - 
15 AG8625 27 M +     - +     - -     -     -     - + - - - - - 
16 AG4055 30 F + + - - - - - - + + + - - - 
17 AG9408 25 M +     - +     - -     -     -     - - - - - - - 
18 AG7238 23 M +     - +     - -     -     -     - + - - - + - 
19 AG2611 31 M + - + - + - - - + - - - + - 
20 755 50 F +     - +     - +     -     +     - - - - - + - 
21 AH172 29 M +     - +     - -     -     -     - - - - - + + 
22 AH459 25 F + - - - + + - - + - + - - - 
23 AH1717 29 F +     - +     - -     -     -     - - - + - + - 
24 AH1424 40 F +     - -     - -     -     +     - + - - - - - 
25 AH3803 38 F + - + - - - - - + - - - - - 
26 AG9003 54 M +     - +     - -     -     +     - + - - - - - 
27 AI8835 56 M +     - +     - +     -     -     - - - + - - - 
28 AG5213 43 M +     - +     - -     -     -     - + - - - + - 
29 AG3487 47 F +     - -     - -     -     -     - - - - - + - 
30 875 56 F +     - +     - +     -     -     - - - - - + - 
  
DISCUSSION 
 
The drug  kariupu parpam was selected to find its efficacy in the management of 
gunmam. 
 
The literary evidence from the text, Anuboga vithiya navaneetham part-3 strongly   
support the anti-ulcer activity of the drug. 
Bio-chemical analysis of the drug kariuppu parpam reveals the presence of slphate, 
copper, sodium, chloride, magnesium, zinc, calcium, phosphate. 
 
COPPER: 
Copper complexs such as copper aspirinate and copper tryptophate, markedly increase 
healing rate of ulcers and wounds.copper complexes heal gastric ulcer five days sooner 
than other  reagents . In siddha text, copper is called as “ Gunmakalan” which it cures 
gunmam (peptic ulcer) . From above the inference it is proved that copper helps in 
healing peptic ulcer. 
 
ZINC: 
It uses in the treatment of peptic ulcer as it is useful  for the repair of damage tissues and 
has shown protective properties against stomach ulceration. 
 
MAGNESIUM: 
Magnesium hydroxide is a more effective antacid than aluminium. It is nonabsorbable 
antacid  so, it is always preferred. It neutralizes the acid. 
 
SULPHATE: 
Sulphur is known as healing mineral, protamine sulphate accelerates gastric ulcer healing 
through a mucosal nitric oxide depedent pathways, acid inhibition properties contributes 
in part to the ulcer healing action of  protamine sulphate. 
 
CALCIUM: 
  
Calcium in the form of calcium carbonate is an antacid. It is an absorbable antacid, which 
neutralizes the stomach acid. 
 
ACUTE TOXICITY STUDY OF KARIUPPU PARPAM: 
In the acute toxicity studies no mortality is occurred up to the leval of 4000mg/kg. It 
proves that the above drug is having wide safety margin. 
 
ANTI-ULCER ACTIVITY: 
 
• The present study shows that kariuppu parpam have a significant antiulcer activity 
as evident from significant decrease in ulcer index in experimently induced gastric 
ulcer model. 
• In pylorus ligation- induced gastric ulceration model a significant decrease in TAO 
was observed. The effect of an agent on mucin activity is reflected by its effect on 
TC/RR ratio. 
• In this model decrease TAO and increased musin activity caused by kariuppu 
parpam may explain    the anti- ulcer action . 
 
SIDDHA ASPECT: 
             According to Siddha aspect ,Gunmam is caused by derangement of vadha kutram 
,so 
 
“uikOlzqm<miz<!lKvl<!HtqBh<H!
OskLxs<!osb<Bl<!sqjxbl<!Ykg<Ogt<!
givf<!Kui<gsh<Hg<!gim<Ml<!Sjuobz<zil<!
sivh<!hiqgivR<!six<X”/!
!
 
ARUSUVAI IMBOOTHAM THIRIDHODAM 
Uvarppu Appu+Theyu Pitham viruthi 
Iya viruthi 
  
 
 
 
 
The compound drug consists of Uvarppu, kaippu, with this the excess valikutram can be 
controlled and it can be mainted by altering pitha kutram . 
 
 
CLINICAL ASSESSMENT: 
 
For the clinical study of kariuppu parpam in gunmam. 30 patients were selected. 
 
According to age wise distribution 30% were in 20-30 yrs, 40% were in 30-40 yrs, 
13.33% were in 40-50 yrs, 16.67% were in 50-60 yrs. 
 
According to sex wise distribution 43.33% were in female , 56.67% were in male. 
 
From  the clinical study 96.67% of patients get relieved from epigastric pain, 95.65% get 
relieved from  Heart burn, 90.90% patients get relieved from nausea, 100% patients get 
relieved from vomiting, 94.74% patients get relieved from indigestion , 100% patients get 
relieved from loss of appetite, 94.44% get relieved from abdominal discomfort and no 
adverse effects were observed. 
 
From the cliical and stastical analysis, it is proved  that the drug kariuppu parpam is 
staistically  significant. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
SUMMARY 
 
The drug kariuppu parpam has been selected for this study to evaluate its efficacy in the 
management of “Gunmam”. 
The litery evidence strongly supports the anti-ulcer activity of kariuppu parpam in the 
management of “Gunmam”. 
Bio-chemical analysis of the drug reveals the presence of sulphate, copper, zinc, calcium, 
magnesium, chloride,sodium and alkaloid, presence of reducing sugar. 
The acute toxicity study study shows that the drug is very safe and no significant adverse 
effects up to dose level to 4000 mg/kg. 
The pharmacological study shows that the drug has significant anti-ulcer activity at the 
dose of 400mg/kg. 
 
From the clinical study, the drug kariuppu parpam is more effective in gunmam . The 
ingredients of drug kariuppu parpam is easily available in all seasons and method of 
preparation is easily and cost effective. 
 
  
CONCLUSION 
From the pharmacological studies and literature evidences and based on the observation 
of their study, it is  concluded that the drug kariuppu parpam has got and Anti- ulcer 
activity , so it can  be given in the management of gunmam. 
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AN OPEN CLINICAL TRIAL OF KUDASAPALAI PATTAI CHOORANAM 
FOR THE  TREATMENT OF KARAPPAN (ECZEMA)-  A  PILOT STUDY 
FORM I-SELECTION PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________5.AGE:_______Yrs 6.GENER:____________ 
 
a)   Nationality  : 
b)   Religion      : 
 
7. DATE OF ADMISSION TO THE TRIAL 
 
8. OCCUPATION: ________________________ 
 
9. POSTAL ADDRESS: ______________________________________ 
 
 ______________________________________ 
 
                                       ______________________________________ 
 
10. COMPLAINS & DURATION: 
                …………………………………………………………………………………… 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
11. HISTORY OF PRESENT ILLNESS: 
                …………………………………………………………………………………… 
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
12. PAST HISTORY: 
                …………………………………………………………………………………… 
……………………………………………………………………………………………… 
 
13. FAMILY HISTORY: 
               ……………………………………………………………………………………. 
……………………………………………………………………………………………… 
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14. MENSTRUAL HISTORY: Normal(1) Abnormal(2)           Not applicable(3)  
                                                          
15. SOCIAL HISTORY: 
     Low socio economic (1) Middle class (2) Higher class (3) 
 
 
HABITS:                                    Yes(1)          No(2) 
16. Smoker  
 
17. Alcoholic 
 
18. Betel nut chewer 
 
19. Non-Vegetarian 
 
 
GENERAL EXAMINATION: 
 
20. a) Built and nutrition 
 
20. b)  Body weight (kg)  : 
 
21. Body temperature (F)       :    
 
22. Blood Pressure (mmHg) : /   
 
23. Pulse Rate/min  : 
 
24. Heart Rate/min  : 
 
25. Respiratory Rate/min : 
 
 
                    Yes (1)          No(2) 
 
26. Pallor  :  
 
27. Jaundice  : 
 
28. Clubbing  : 
 
29. Cyanosis  : 
 
30. Pedal Oedema  : 
 
31. Lymphadenopathy  : 
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32. Jugular venous pulsesation    : 
 
 
CLINICAL EXAMINATION OF SKIN: 
 
33. ANATOMICAL LOCATION…………………………………. 
 
 
34. COLOUR -Normal            Hyperpigmented                 Hypopigmented 
 
35. SIZE OF THE LESION (Length cm): ……………………………     
 
36. SHAPE:            Irregular             Round                    Dispersed 
 
37. PRURITUS:       Present                     Absent 
 
38. SWELLING:      Present                    Absent 
 
39. ERYTHEMA:    Present                     Absent 
 
40. DEPIGMENTATION OF SKIN 
 
                                 Present  Absent 
 
41. SENSATION 
 
                              Normal                     Paraesthesia                     Numbness 
 
  Painful                     Burning                            Pricking  
 
42. SCALING:        Present      Absent 
 
43. CRUSTING:       Present      Absent 
 
44. OOZING:            Present      Absent 
 
45. MACULES:        Present      Absent 
 
46. PAPULES:          Present      Absent 
 
47. VESICLES:         Present      Absent 
 
48. PUSTULES:        Present      Absent 
 
49. PALPATION: 
                                Normal                          Smooth                              Rough 
                        
                               Warm                             Cold 
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EXAMINATION OF VITAL ORGANS: 
 
                                          Normal (1)          Abnormal (2) 
50. CNS                                                                ...………………………………… 
 
51. CVS                                                               ………………………………….. 
 
52. RS                                                                       …….............................................. 
 
53. ABDOMEN                                                       ………………………………….. 
 
54. NILAM: 
 
1.Kurinji                2.Mullai              3.Marutham              4.Neithal              5.Palai    
 
55. KALA  IYALBU: 
  
1.Karkaalam                    2.Koothirkaalam                   3.Munpanikaalam            
 
4.Pinpanikaalam              5.Illavenilkaalam                 6.Muthuvenilkaalam 
 
56. UDAL  IYALBU: 
 
1.Vadam          2.Pitham           3.Kabam           4.Vathapitham            5.Vathakabam 
 
6.Pithavadam             7.Pithakabam              8.kabavadham               9.Kabhapitham 
 
57.GUNAM: 
 
            1. Sathuvam                       2.Rasatham                          3.Thamasam 
 
AYMPORIGAL: 
                                     Normal(1)          Affected(2) 
 
             58. Mei                                                   ................................................... 
 
             59. Vaai                                                      ………………………………… 
 
 60 Kan                                                       ………………………………… 
 
 61. Mookku                                                ………………………………… 
          
 62. Sevi                                                      …………………………………. 
 
KANMENTHIRIUM / KANMAVEDAYAM 
 
                                   Normal(1)            affected(2) 
             63. Kai                                                        …………………………………….. 
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             64 Kaal    …………………………………….. 
 
             65. Vaai   …………………………………….. 
 
            66. Earuvai   …………………………………….. 
 
             67 Karuvai     …………………………………….. 
    
  UYIR THATHUKKAL: 
 
     VATHAM: 
                                        Normal (1)            affected (2)    
68 Pranan   ……………………………………………….   
   
 69 Abanan   ……………………………………………….. 
  
 70.Viyanan    ……………………………………………….. 
 
             71.Uthanan    ……………………………………………….. 
 
 72.Samanan    ………………………………………………... 
 
 73.Nagan    ……………………………………………….. 
 
             74.Koorman   ………………………………………………..  
 
 75.Kirukaran    ……………………………………………… 
 
 76.Devathathan    ………………………………………………. 
 
            77.Dhananjeyan     ……………………………………………….. 
 
     
     PITTHAM:   
                                         Normal (1)            affected (2)     
78.Anar pittham     …………………………………………….. 
         
 79.Ranjagam   ……………………………………………… 
 
 80.Sathagam   ………………………………………………. 
 
 81.Alosagam   ……………………………………………… 
 
 82.Prasagam       ……………………………………………….   
 
     KABAM: 
 
                                         Normal (1)            affected (2)     
   83.Avalambagam   ………………………………………………..  
 
  84.Kilethagam             ………………………………………………. 
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  85.Pothagam   …………………………………………………. 
 
 86.Tharpagam    ………………………………………………. 
 
 87.Santhegam                                            ……………………………………………… 
 
 
UDAL THATHUKKAL: 
                                        Normal (1)            affected (2)    
88. Saaram   ………………………………………………  
 
89.Senneer           ………………………………………………. 
 
90.Oon           ………………………………………………. 
 
91.Kozhuppu                         ………………………………………………. 
 
  92.Eanbu              ……………………………………………… 
 
93..Moolai                                              ……………………………………………… 
 
94.Sukkilam/                               
  Suronitham                                       ……………………………………………….. 
 
ENVAGAI THERVUGAL: 
 
 95. Naadi    ………………………………………………………………. 
                                     Normal (1)            affected (2)    
96.Naa  
 
97. Niram  
 
 98.Mozhi  
 
99.Vizhi  
 
 100.Sparisam  
 
 Malam:                   Normal (1)            affected (2)    
       101. Niram 
       102. Nurai 
 
       103. Kirumi  
 
       104. Kalappu 
 
       105. Erugal 
 
       106. Elagal 
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Mootheram: 
       Neerkuri: 
                                Normal (1)            affected (2)   
            107. Niram        
 
            108.Manam       
 
             109.  Eadai                                                       
 
     110.Nurai 
 
     111.Enjal  
 
      Neikuri:     Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
                               
LAB INVESTIGATION: 
BLOOD: 
112. TC (Cells/Cu mm) 
 
 DC (%)-   113.N-                  114.L-                115..M-              116.E -               117.B- 
 
 ESR (mm)- 118. 1/2 hr-                           119.1 hr- 
 
120. Hb (gm%)-                
   
Blood Sugar (gm %) 
121.Fasting                              122.Post Prandial 
                  
123.Randam  
 
124.Blood Urea(mg%) 
 
125.Blood Cholesterol(mg%) 
 
  
URINE:                             Present (1)         Absent (2)                                          
126.Albumin                                                        ……………………………............. 
  
127.Sugar                                                             …………………………………… 
 
      
  Deposit                          Present (1)         Absent (2)                                          
         128.Pus cells            -                                     …………………………………… 
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 129.Epithelial cells  -                                 …………………………………… 
 
 130.Red cells            -                                     …………………………………… 
 
 131.Casts/Crystal     -                                    …………………………………… 
 
 
 
MOTION:                        Present (1)         Absent (2)   
                                        
132.Ova  - 
  
133.Cyst                     -  
                                                                    
134.Occult blood         - 
 
135.Pus cells              - 
 
 
 
146.Admitted to trail:    (1)  Yes     aaaa  (2)  No 
 
147.If yes, a) S.No:                 149.IP:               OP: 
 
 
148.Drugs issued for O.P.Patients: 
 
 1.No.of  packs:__________ 
 
                                                                                                      Signature of investigator 
149..Date:………………… 
 
150.Station:……………….                                                           Signature of Doctor 
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AN OPEN CLINICAL TRIAL OF  KUDASAPALAI PATTAI  CHOORANAM 
FOR THE TREATMENT OF KARAPPAN  (ECZEMA)- A  PILOT STUDY 
 
FORM II-ASSESSMENT PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________ 
 
5. DATE OF ADMISSION: 
 
6. DATE OF ASSESSMENT: 
 
7. DAY OF ASSESSMENT: 
 
CLINICAL ASSESSMENT CHART: 
 
8. ANATOMICAL LOCATION…………………………………. 
 
9. COLOUR           Normal              Hyperpigmented                 Hypopigmented 
 
10. SIZE OF THE LESION (Length cm):……………………………     
 
11. SHAPE:            Irregular          Round                    Dispersed 
 
12. PRURITUS:       Present                     Absent 
 
13. SWELLING:      Present                     Absent 
 
14. ERYTHEMA:     Present                    Absent 
 
15. DEPIGMENTATIOPN OF HAIR 
 
                                 Present  Absent 
 
16. SENSATION 
 
                              Normal                 Paraesthesia                     Numbness 
 
  Painful                 Burning                            Pricking  
 
17. SCALING:        Present      Absent 
 
18. CRUSTING:       Present      Absent 
                                                                      1 
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19. OOZING:            Present      Absent 
 
20. MACULES:        Present      Absent 
 
21. PAPULES:          Present      Absent 
 
22. VESICLES:         Present      Absent 
 
23. PUSTULES:        Present      Absent 
 
24. PALPATION: 
                                Normal                          Smooth                              Rough 
                        
                                Warm                             Cold 
 
25.PIGMENTATION   :          Present            Absent 
 
      ………………………………………………………………………………………….. 
 
26.Naadi……………………………………………………………………………………. 
                                             
LAB INVESTIGATION :( Only on Day 1, 21and Day 48) 
BLOOD: 
27. TC (Cells/Cu mm) 
 
DC (%)      28.N-                       29.L-                  30.M-              31.E -                32.B- 
 
ESR (mm) 33.1/2 hr-                             34.1 hr- 
 
35. Hb (gm %)-                
   
Blood Sugar(gm%) 
36.Fasting                               37.Post Prandial 
                  
38.Randam  
 
39.Blood Urea(mg%) 
 
40.Blood Cholesterol(mg%) 
  
 
URINE:                             Present (1)         Absent (2)                                          
41.Albumin                                                        ……………………………............. 
  
42.Sugar                                                             …………………………………… 
 
                                                                2 
    Deposit                          Present (1)         Absent (2)                                          
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 43.Pus cells            -                                     …………………………………… 
 
 44.Epithelial cells  -                                 …………………………………… 
 
 45.Red cells            -                                     …………………………………… 
 
 46.Casts/Crystal     -                                    …………………………………… 
 
MOTION:                        Present (1)         Absent (2)                                          
47. Ova  - 
  
48. Cyst  - 
 
49. Occult blood- 
 
50. Pus cells - 
 
51. NEERKURI………………………………………………………………………… 
 
52. NEIKURI:           Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
 
 
53. RESULT:            Cured                         Improved                       No change 
 
FOR O.P.PATIENTS: 
54. Drugs returned: 
    1. No of packs:……………..   
 
55. Drugs issued: 
   1. No. of pack……………… 
 
 56. ENVAGAI THERVUGAL 
 
    Naa 
    Niram 
    Mozhi 
    Vizhi 
    Malam 
    Neer 
    Naadi 
    Sparism 
                                                                                                Signature of investigator 
57.  Date: 
58.  Station:                                                                                   Signature of Doctor 
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A CLINICAL TRIAL OF SIDDHA DRUG KUDASAPALAIPATTAI  
CHOORANAM FOR THE TREATMENT OF KARAPPAN (ECZEMA) 
- A PILOT STUDY 
 
CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               
by the patient. 
 
Date: _____________ 
                                                            Signature: ________________ 
Station: ___________ 
                                                            Name: ____________________ 
 
                                              
                                                   CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of the drug treatment and follow-up including the laboratory 
Sinvestigations to be performed to monitor and safeguard my body functions. 
 
  I, exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of Kudasapalaipattai chooranam on Karappan. 
 
  Date: _____________                                            
                                                                Signature: _________________ 
  
 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
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AN OPEN CLINICAL TRIAL  OF KARIUPPU PARPAM FOR THE  
TREATMENT OF GUNMAM(PEPTIC ULCER)   - A  PILOT STUDY 
 
FORM I-SELECTION PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________5.AGE:_______Yrs 6.GENER:____________ 
 
a)   Nationality   : 
b)   Religion       : 
 
7. DATE OF ADMISSION TO THE TRIAL 
 
8. OCCUPATION: ________________________ 
 
9. POSTAL ADDRESS: ______________________________________ 
 
 ______________________________________ 
 
                                       ______________________________________ 
 
10. COMPLAINTS & DURATION: 
                …………………………………………………………………………………… 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
11. HISTORY OF PRESENT ILLNESS: 
                …………………………………………………………………………………… 
………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
12. PAST HISTORY: 
                …………………………………………………………………………………… 
……………………………………………………………………………………………… 
 
13. FAMILY HISTORY: 
               ……………………………………………………………………………………. 
……………………………………………………………………………………………… 
 
14. MENSTRUAL HISTORY: Normal(1) Abnormal(2)           Not applicable(3)  
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15. SOCIAL HISTORY: 
     Low socio economic (1) Middle class (2) Higher class (3) 
 
HABITS:                                    Yes(1)          No(2) 
16. Betel nut chewer  
 
17. Tea  /Coffee 
 
18. Non-Vegetarian  
 
19. Alcoholic                                 
 
20. Smoker /Tobacco 
 
GENERAL EXAMINATION: 
 
21  a) Built and  nutrition 
 
      b) Body weight (kg)  : 
 
22. Body temperature (F)       :    
 
23. Blood Pressure (mmHg) : /   
 
24. Pulse Rate/min  : 
 
25. Heart Rate/min  : 
 
26. Respiratory Rate/min : 
 
                    Yes (1)          No(2) 
 
27. Pallor  :  
 
28. Jaundice  : 
 
29. Clubbing  : 
 
30. Cyanosis  : 
 
31. Pedal Oedema  : 
 
32. Lymphadenopathy  : 
 
33. Jugular venous pulsesation    : 
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EXAMINATION OF VITAL ORGANS: 
 
                                          Normal (1)          Abnormal (2) 
34.Stomach                                                              ...………………………………… 
 
35.Liver                                                            ………………………………….. 
 
36.Spleen                                                                 …….............................................. 
 
37.Kidney                                                                  …………………………………… 
 
38. Lungs                                                                   ………………………………….. 
 
39. Heart                                                                     ……………………………………..                                        
                                        
40.Brain                                                                      ………………………………………..     
                                          
 CLINICAL EXAMINATION 
   
SIGNS AND SYMPTOMS         Yes                No 
              
41. EPIGASTRIC PAIN                               
 
42. HEART BURN                                               
 
43. NAUSEA 
 
44. VOMITING                          
 
45. INDIGESTION                                                                                       
                                                  
46. ABDOMINAL DISCOMFORT         
                                                                                        
                                                                                                                                                            
SIDDHA SYSTEM EXAMINATION 
 
AYMPORIGAL: 
                                     Normal(1)          Affected(2) 
 
      47. Mei                                                   ................................................... 
 
      48. Vaai                                                      ………………………………… 
 
      49.  Kan                                                       ………………………………… 
 
      50.  Mookku                                                ………………………………… 
          
      51. Sevi                                                      …………………………………. 
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KANMENTHIRIUM / KANMAVEDAYAM 
 
                                   Normal(1)            affected(2) 
                   
             52. Kai                                                     ........................................................ 
 
             53 Kaal    …………………………………….. 
 
             54. Vaai   …………………………………….. 
 
             55. Earuvai   …………………………………….. 
 
             56. Karuvai     …………………………………….. 
 
                                       
57. NILAM: 
 
1.Kurinji                2.Mullai              3.Marutham              4.Neithal              5.Palai    
 
58.  PARUVA KAALAM   
  
1.Karkaalam                    2.Koothirkaalam                   3.Munpanikaalam            
 
4.Pinpanikaalam              5.Elavenilkaalam                 6.Muthuvenilkaalam 
 
59  YAKKAI : 
 
1.Vatham          2.Pitham           3.Kabam           4.Vathapitham            5.Vathakabam 
 
 
6.Pithavadam             7.Pithakabam              8.kabavadham               9.Kabhapitham 
 
60 .GUNAM: 
 
            1. Sathuvam                       2.Rasatham                          3.Thamasam 
                                                                          
                                                                          
UYIR THATHUKKAL: 
     VATHAM: 
                                        Normal (1)            affected (2)    
     61. Pranan   ……………………………………………….   
   
     62. Abanan   ……………………………………………….. 
  
     63.Viyanan    ……………………………………………….. 
 
     64. Uthanan    ……………………………………………….. 
 
    65.Samanan    ………………………………………………... 
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            66 .Nagan    ……………………………………………….. 
 
            67 Koorman   ………………………………………………..  
 
            68. .Kirukaran    ……………………………………………… 
 
            69 .Devathathan    ………………………………………………. 
 
           70.Dhananjeyan     ……………………………………………….. 
     
     PITTHAM:   
                                         Normal (1)            affected (2)     
71.Anar pittham     …………………………………………….. 
         
 72.Ranjagam   ……………………………………………… 
 
 73..Sathagam   ………………………………………………. 
 
 74.Alosagam   ……………………………………………… 
 
 75.Prasagam       ……………………………………………….   
 
     KABAM: 
                                         Normal (1)            affected (2)     
   76.Avalambagam   ………………………………………………..  
 
 77.Kilethagam   ………………………………………………. 
 
 78.Pothagam    ……………………………………………… 
 
 79.Tharpagam    ………………………………………………. 
 
 80.Santhegam                                            ……………………………………………… 
 
UDAL THATHUKKAL: 
                                        Normal (1)      affected (2)    
81. Saaram   ………………………………………………  
 
82.Senneer           ………………………………………………. 
 
83.Oon           ………………………………………………. 
 
84.Kozhuppu                         ………………………………………………. 
 
  85.Eanbu              ……………………………………………… 
 
86..Moolai                                              ……………………………………………… 
 
87.Sukkilam/                               
  Suronitham                                       ……………………………………………….. 
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ENVAGAI THERVUGAL: 
 
88. Naadi    ………………………………………………………………. 
                                     Normal (1)            affected (2)    
89.Naa  
 
90.Niram  
 
 91..Mozhi  
 
92..Vizhi  
 
 93.Sparisam  
 
 
 Malam:                   Normal (1)            affected (2)    
       94. Niram 
 
       95. Nurai 
 
       96 Kirumi  
 
       97. Kalappu 
 
       98. Erugal 
 
       99. Elagal 
 
Mootheram: 
 
       Neerkuri: 
                                Normal (1)            affected (2)   
       100. Niram        
 
        1O1.Manam       
 
       102.  Edai 
 
     103. Nurai 
 
     104.. Enjal  
 
 
      Neikuri:     Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
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LAB INVESTIGATION: 
 
BLOOD: 
105. TC (Cells/Cu mm) 
 
 DC (%)-   106.P-                  107.L-                108..M-              109.E -               110.B- 
 
 ESR (mm)- 111. 1/2 hr-                           112.1 hr- 
113. Hb (gm%)-               
   
Blood Sugar (gm %) 
114.Fasting                              115.Post Prandial 
                  
116.Randam  
 
117Blood Urea(mg%) 
 
118.Blood Cholesterol(mg%) 
  
 
URINE:                             Present (1)         Absent (2)                                          
119.Albumin                                                        ……………………………............. 
  
120.Sugar                                                             …………………………………… 
 
       Deposit                          Present (1)         Absent (2)                                          
         121.Pus cells            -                                     …………………………………… 
 
 122.Epithelial cells  -                                 …………………………………… 
 
 123.Red cells            -                                     …………………………………… 
 
 124.Casts/Crystal     -                                    …………………………………… 
 
 
MOTION:                        Present (1)         Absent (2)   
                                        
125.Ova  - 
  
126.Cyst                     -  
                                                                    
127.Occult blood             - 
 
128. Pus cells              - 
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 ENDOSCOPY :         ………………………………………………………………… 
 
……………………………………………………………………………………………. 
 
 
                                                                                                         
129.Admitted to trail:       (1) Yes                 2)  No 
 
130.If yes, a) S.No:                 147O P:              IP: 
 
 
 
131.Drugs issued for O.P.Patients: 
 
 1.No.of  packs:__________ 
 
 
 
132.Date:…………………                                                          
 
                                                                                                 Signature of  investigator 
 
 
133. Station:……………….                                                         Signature of Doctor 
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AN OPEN CLINICAL TRIAL OF “KARIUPPU PARPAM”  FOR 
THE  TREATMENT  OF  GUNMAM (PEPTIC ULCER) - A  PILOT STUDY 
 
FORM II-ASSESSMENT PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________ 
 
5. DATE OF ADMISSION: 
 
6. DATE OF ASSESSMENT: 
 
7. DAY OF ASSESSMENT: 
 
CLINICAL ASSESSMENT CHART: 
 
8. EPIGASTRIC PAIN 
 
9. HEART BURN                        
 
10. NAUSEA 
 
11. VOMITING                          
 
12. INDIGESTION                
 
13. ABDOMINAL DISCOMFORT         
                                                   
14..NAADI……………………………………………………………………………… 
 
 
15.EN VAGAI THERVU 
      
     NAA 
     NIRAM  
     MOZHI 
     VIZHI  
     MALAM  
     NEER 
     NAADI 
     SPARISM 
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LABORATORY INVESTIGATION :( ON 24th  Day)  
  BLOOD 
 
                                                                    
16.TC (Cells/ cu mm) 
 
 
DC (%)      17.N-                       18.L-                  19.M-              20.E -               21.B- 
 
ESR (mm) 22.1/2 hr-                             23.1 hr- 
 
24. Hb (gm %)-               
 
 
BIood Sugar(gm%) 
 
25.Randam             
                                                                                                                  
26..Blood Urea(mg%)                                                   
 
27..Blood Cholesterol(mg%) 
  
URINE:                             Present (1)         Absent (2)                                          
28.Albumin                                                        ……………………………............. 
  
29.Sugar                                                             …………………………………… 
 
                                                                 
    Deposit                          Present (1)         Absent (2)                                          
 30.Pus cells            -                                     …………………………………… 
 
 31.Epithelial cells  -                                 …………………………………… 
 
 32.Red cells            -                                     …………………………………… 
 
 33.Casts/Crystal     -                                    …………………………………… 
 
 
 
34 NEERKURI………………………………………………………………………… 
 
35. NEIKURI:           Vatha neer(1)              Pitha neer(2)              Kaba neer(3) 
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36. RESULT:            Cured                         Improved                       No change 
 
 
 
FOR O.P.PATIENTS: 
 
37. Drugs returned:  
 
    1. No of packs:……………..   
 
38. Drugs issued:  
 
  1. No. of pack……………… 
 
 
 
 
 39.  DATE .                                                                                   
 
 40 .STATION:                                                                                    
 
                                                                                                 Signature of the investigator 
 
                                                                                                 
                                                                                                 Signature of the Staff  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24
A CLINICAL TRIAL OF SIDDHA DRUG KARIUPPU PARPAM  
FOR THE TREATMENT OF GUNMAM (PEPTIC ULCER) 
- A PILOT STUDY 
 
CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               
by the patient. 
 
Date: _____________ 
                                                            Signature: ________________ 
Station: ___________ 
                                                            Name: ____________________ 
 
                                              
                                                   CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of the drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 
  I, exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of Kariuppu parpam on Gunmam. 
 
  Date: _____________                                            
                                                                Signature: _________________ 
  
 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
     
 
 
 
 
 
 
 
 
